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SOMMAIRE
La valeur pronostique d’une fréquence cardiaque au repos (FCR) basse chez les patients avec
angine chronique stable (ACS) est inconnue. La réponse de la fréquence cardiaque (FC) à l’effort
pourrait également nous donner des informations additionnelles sur ces patients.
Les objectifs de ce mémoire sont d’étudier la valeur pronostique de la FCR chez les patients avec
ACS et d’explorer la relation entre les différentes mesures du comportement de la fC à l’effort et
la mortalité totale et cardiovasculaire (CV) à long tenue.
Nous avons obtenu la FCR de 24 913 patients du registre Coronary Artery Surgery Study (CASS)
avec soupçon ou diagnostique de maladie coronarienne athéromateuse (MCAS) avec un suivi
médian de 14,7 ans. Les risques de mortalités totale et cardiovasculaire étaient augmentés avec
une fCR plus élevée (p< 0,0001). Lors de la comparaison des patients avec une FCR 62 bprn,
les patients avec une FCR 83 bpm avaient un risque significativement augmenté de mortalité
totale (hazard ratio = 1,32; 99% Cl 1,19-1,47) et de mortalité CV (hazard ratio = 1,31; 99% CI
1,15-1,48) après ajustement pour plusieurs variables cliniques. Ils avaient aussi un taux de
réhospitalisation pour causes CV élevé (hazard ratio 1,14; 99% CI 1,02-1,27).
2 793 patients du même registre ont subi une épreuve d’effort tEE). L’incompétence
chronotropique exprimée comme <80% de la réserve de la FC (HRRes) était un prédicteur
significatif de mortalité totale et CV (p <0,0001). Les patients avec un %HRRes élevé avaient un
risque significativement plus bas de mortalité totale et CV (hazard ratio pour chaque
augmentation d’un écart type = 0,79; 95% CI 0,71-0,88 pour les deux types de mortalité) après
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ajustement pour plusieurs variables cliniques. Le %HRRes était la mesure du comportement de la
FC à l’effort qui contribuait le plus aux modèles.
La FCR est un prédicteur indépendant de la mortalité totale et CV chez les patients avec MCAS.
Parmi les diverses mesures de FC à l’effort, le %HRRes est le meilleur prédicteur de mortalité
totale et CV chez ces patients et il devrait dorénavant être inclus dans tous les rapports
d’épreuves d’effort.
Mots clés : fréquence cardiaque au repos, pronostique, maladie coronarienne, incompétence
chronotropique, réserve de la fréquence cardiaque, épreuve d’effort, mortalité, mortalité
cardiovasculaire.
VABSTRACT
Low resting heart rate (RHR) lias unknown prognostic value in patients with chronic stable
angina (CSA). Additionally, heart rate response to exercise could provide further useful
information in such patients.
The goals ofthis thesis are to study the prognostic value ofRHR in a population of patients with
CSA and to explore the reiationship between different heart rate measures during exercise
treadmill test (ETT) and long-tenn total and cardiovascular (CV) mortality.
We obtained tlie RHR of 24 913 patients from the Coronary Artery Surgery Study (CASS)
database with suspected or proven coronary artery disease and a median follow-up of 14.7 years.
Patients with resting heart rate ? 83bpm at baseline had a significantly higher risk for total
(hazard ratio = 1.32, 99% CI 1.19-1.47) and CV mortality (hazard ratio = 1.31, 99% CI 1.15-
1.48) afler adjustment for multiple clinical variables compared to the reference group. The hazard
ratio for time to first CV rehospitalization in these patients was 1.14, 99% CI 1.02-1.27.
A total of 2 793 patients from the same registry underwent ETT. Chronotropic incompetence
expressed as a low (<80) % heart rate reserve (HRRes) was a predictor for all-cause and CV
mortality Q, <0.0001). Patients with a higher %HRRes liad a significantly lower risk of total and
CV mortality (hazard ratio = 0.79, 95% CI 0.71-0.88 for both outcomes for each increase ofone
standard deviation) after adjustment for multiple clinical covariates. Out of ail exercise heart rate
measurements, %HRRes contributed the most to the models.
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RHR is a strong, independent predictor for total and CV mortality in patients with coronary
artery disease. % HRRes is the best heart rate predictor during exercise for total and CV mortality
in these patients and it should be routinely included in ail ETT.
Key words: resting heart rate, prognosis, coronary disease, chronotropic incompetence, heart rate
reserve, exercise treadmiil test, mortaÏity, cardiovascular mortality.
vii
INDEX
SOMMAIRE iii
ABSTRACT y
LIST 0F TABLES xi
LIST 0F FIGURES xii
LIST 0F ABBREVIATIONS xiv
ACKNOWLEDGEMENTS xvi
CHAPTER 1: INTRODUCTION 2
1.2 Historical background 2
1.3 Rationale for the study ofthis association between heart rate and rnortality 6
1.3.1 Phylogenetic perspective 7
1.3.2 Molecular perspective 9
1.3.3 Pathological perspective 9
1.3.4 Clinical perspective 11
1.3.5 Genetic perspective 12
1.3.6 Previous epidemiologic studies assessing the relationship 14
1.4 Pathophysiology of the association between heart rate and cardiovascular events 16
1.4.1 Autonomic disbalance 16
1.4.2 Tachycardia as an independent mechanism ofrisk for mortality 17
1.5 Heart rate and exercise 18
1.5.1 Maximal heart rate during exercise treadmiil test 19
viii
1.5.2 Age-predicted maximal heart rate 20
1.5.3 Heart rate recovery 20
1.5.4 Percentage ofheart rate reserve 21
1.6 General goals of this thesis and hypothesis to be tested 23
CHAPTER 2. METHODS 25
2.1.1 Database and study group description 26
2.1.2 Jriformed consent 2$
2.1.3 Baseline data collection and variables description 2$
2.1.4 Patients follow-up 32
2.2 Statistical analyses 33
2.2.1 Variable selection and treatment 33
2.2.2 Descriptive statistics 36
2.2.3 Survival analysis 36
CHAPTER 3. LONG TERM PROGNOSTIC VALUE 0F RESTING HEART RATE IN
PATIENTS WITH SUSPECTED OR PROVEN CORONARY ARTERY DISEASE 38
Abstract 40
Introduction 41
Methods 41
Resuits 45
Discussion 47
ix
Conclusions .49
References .50
Tables 53
Figures 59
CHAPTER 4. PERCENT HEART RATE RESERVE DURING EXERCISE HAS
INDEPENDENT PROGNOSTIC VALUE IN PATIENTS WITH SUSPECTED OR
PROVEN CORONARY ARTERY ifiSEASE 65
Abstract 67
Introduction 70
Methods 71
Results 75
Discussion 77
Conclusions 80
References $1
Tables 86
figures 90
CHAPTER 5. DISCUSSION AND CONCLUSIONS 93
5.1 Main resuits and original contribution 94
5.2 Confounding variables 94
5.2.1 -adrenergic receptor antagonists 95
X5.2.1 Ejection fraction .96
5.3 Study limitations 97
5.4 General conclusions 98
CHAPTER 6. REFERENCES 99
CHAPTER 7. ANNEXES 108
7.1 Autorisation de déposer ce mémoire de maîtrise sous forme d’articles
7.1.1 Autorisation des coauteurs
7.2 Autorisation de rédiger ce mémoire en langue anglaise
xi
LIST 0F TABLES
TABLE 1-I Epiderniologic studies assessing resting heart rate and total or
cardiovascular mortality 15
TABLE 2-I List ofvariables 35
TABLE 3-I Descrtption ofvariables used in this study 53
TABLE 3-II Baseline characteristics divided by resting heart rate in quintiles 54
TABLE 3-III Multivariable Cox regression survival analysis for total inortaÏity 55
TABLE 3-IV Multivariabte Cox regression survival analysis for cardiovascutar
inortatity 56
TABLE 3-V Muttivariable Cox regression analysisfor time to rehospitalization
due to any cardiovascular cause or acute myocardiat iifarction 57
TABLE 3-VI Cox regression analysis for time to rehospitalization due to angifla,
stroke or congestive heartfailure 5$
TABLE 4-I Definition ofvariables in article two $6
TABLE 4-II Baseline characteristics by chronotropic incompetence 87
TABLE 4-III Wald test results ofdfferent heart rate pararneters and number of
METS duriizg exercise 88
TABLE 4-IV Multivariate Cox regression survival analysis for total and
cardiovascular mortality 89
xii
LIST 0F FIGURES
FIGURE l-1 Ebers papyrus 3
FIGURE 1-2 The pulse classic 4
FIGURE 1-3 Exercitatio Anatomica de Mottts Cordis et Sanguinis ut animatibus 5
FIGURE 1-4 Man’ey sphygmograph 6
FIGURE 1-5 Semilogarithrnic relation between Ïieart rate and lfe expectancy in
maminals 7
FIGURE 1-6 Relation between lfe expectancy and total heartbeats in a
LiJetiine antong inanunaïs 8
FIGURE 1-7 Autonontic inibalance and CVevents 17
FIGURE 1-8 The metabolic chronotropic relation 22
FIGURE 2-1 CASSpatientsflow diagram 27
FIGURE 2-2 Termiizologyfor coronaiy artely anatonly visualïzed at
angiography utilized by cooperating sites in C4$S 31
FIGURE 3-1 Adjusted survival curves for overail rnortality by resting heart
rate quintiles 60
FIGURE 3-2 Adjusted survival curves for cardiovasctdar ntortality by resting
heart rate quintiles 61
FIGURE 3-3 Adjusted survival curves for tinte to rehospitatization due to any
cardiovascular cause 62
FIGURE 3-4 Adjusted survival curves for tirne toflrst rehospitalization due to
congestive heartfailure 63
FIGURE 3-5 Subgroup analvsis on total mortality per standard deviation
xiii
(12.4 bpm) ofresting heart rate .64
FIGURE 4-l Adjusted sun’ival ctcrves for total inortaÏity by
chronotropic incompetence 91
FIGURE 4-2 Adjusted survival curves for cardiovascutar mortality
by chronotropic incompetence 92
xiv
LIST 0F ABBREVIATIONS
ACC / AHA: American College of CardioÏogy / American Heart Association
ACS: Angine Chronique Stable
APMHR: Age-Predicted Maximal Heart Rate
ATP: Adenosine Triphosphate
BMI: Body Mass Index
CAD: Coronary Artery Disease
CASS: Coronary Artery Surgery Study
CHF: Congestive Heart Failure
CI: Confidence Interval
CSA: Chronic Stable Angina
CV: Cardiovascular / Cardiovasculaire
DM: Diabetes Mellitus
EDV: Left ventricular End-Diastolic Volume
ESV: Left ventricular End-Systolic Volume
EE: Épreuve d’Effort
EF: Ejection Fraction
ETT: Exercise Treadmili lest
FC: Fréquence Cardiaque
FCR: Fréquence Cardiaque au Repos
HDL: High-Density Lipoprotein
HRmax: Maximal Heart Rate during exercise
HRRec: Heart Rate Recovery after exercise
xv
HRRes: Heart Rate Reserve during exercise
HTN: Hypertension
LAD: Left Anterior Descending Coronary Artery
LCx: Lefi Circumilex Coronary Artery
LMCA: Left Main Coronary Artery
MCAS: Maladie Coronarienne Athéromateuse
MCR: Metabolic chronotropic relation
MI: Myocardial Infarction
NCVD: Number of Clinically significant coronary Vessel Disease
PH: Proportional Hazard
QTL: Quantitative Trait Loci
RC: Right Coronary Artery
RHR: Resting Heart Rate
SD: Standard Deviation
xvi
ACKNOLEDGEMENIS
Thank you Dr. Tardif for your support and dedication to ail of this. You are an example of
physician, researcher and above ail of a mentor. Thank you for the impeccable review of each
article ami for the timc you dedicated to each of them. Rack then you believed in me and I will
neyer forget that.
Mane-Claude, yoti did everything easier with your judicious, wanii and friendly advice. Thank
you very much for aiways answering ALL my biostats questions.. .You were aiways there ready
to listen and encourage me. Tu avais raison, il fait bon vivre au Québec!
Dr. Bourassa you are a mode! ofwhat I consider a great researcher should be. Only your modesty
surpasses your wisdom. Thank you for your intellectual contribution to this thesis.
Merci à tout l’équipe du centre de coordination de l’ICM (MHICC) pour votre amitié, pour toutes
les tasses de café et chaque tape dans le dos. Spécialement merci à Sylvie Lévesque pour sa
patience et temps à m’expliquer les innombrables doutes en biostatistique.
finalement merci à tous mes amis et famille pour leur support et patience
To my parents, who aiways guide and enlighten my way with their example.
A mis padres, quienes siempre guan e iluminan mi camino con su ejemplo.
To my ever understanding beloved wife. Thank you for your unconditional support.
CCHAPTER I
INTRODUCTION
21. INTRODUCTION
Although measuring resting heart rate (RHR) is practically a reflex we ail learn in medical
school, there are stiil many unanswered questions regarding its genuine value and prognosis. The
modem physician faces state-of-the-art technology on daily basis. Preventive, diagnostic,
therapeutic and reliabilitation medical acts Ïargely depend on sornetimes complicated and
expensive procedures. Certainly, every clinician measures bis or ber patient’s heart rate.
Nevertheless, it is the value we bestow to our patients’ heart rate which bas becorne nurnbed.
UsualLy, physicians would only pay attention to beart rate in certain critical clinical conditions
such as hemodynamic instability, hyperthermia, drug toxicity and the like. Yet, how rnuch does
RHR influence the occurrence of cardiovascular events? Is there an intrinsic benefit to a lower
RHR? What is the prognostic value of RHR in patients with stable coronary artery disease
(CAD)? In addition, what is the prognostic value of heart rate during exercise? In this thesis I
intend to further explore and describe the association ofRHR and survival in a general population
of patients referred for a coronary angiogram due to suspected or confirmed CAD. In addition,
the relationship between heart rate during exercise and long-term survival will be also assessed.
1.2 Historical background.
From the times ofthe Eberpapyrus 1700 BC, the pulse has been recognized as a benchmark for
cardiovascular assessment (Figure 1-1). The papyrus stated as regards to the pulse “it is there that
the heart speaks” establishing the connection between the heart and peripheral pulse.
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figure 1-1 Ebers papyrus referring to the pulse, ca 1700 BC. Egypt. Courtesy of the National
Library of Medicine
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Furthermore, the observation of decreased heart rate variability as a predictor of sudden cardiac
death has been known for centuries. The Chinese physician Wang Shuhe, (265—3 17 A.D.) wrote
in The Pulse Classic, “If the pattem of the heart beat becomes as regular as the tapping of a
woodpecker or the dripping of ram from the roof, the patient will be dead in four days”(l)
(Figure 1-2). This observation already linked a decrease in heart rate variability to mortality.
4It was not until 162$ that the western world acknowledged the connection between the peripheral
arterial pulse and the heart. In that year Sir William Hawey (1578-1657) dedicated to Prince
Charles I King ofBritain, france and Ireland bis famous “Treatise on The Motion oJThe Heart
and Blood in Animais”. In that treatise, he wrote
“. .From these facts it is manifest, in opposition to commonly received opinions, that the diastole
of the arteries corresponds with the time of the heart’s systole; and that the arteries are filled and
distended by the blood forced into them by the contraction of the ventricles; the arteries,
therefore, are distended, because they are filled like sacs or bladders”
Figure 1-2. Doctor Wang Shuhe writing The Pulse Classic, which is the earliest comprehensive
work dealing with several kinds of pulses and their diagnostic value (from Liu YC. The Essential
Book of Traditional Chinese Medicine. New York: Columbia University Press, 198$: 4).
5(2) (figure 1-3). The pulse has always been the center of much medical attention and extensive
essays. Many illustrated physicians left their names attached to a pulse disorder such as Corrigan,
Kussmaul and Riegel just to name a few. It was flot until 1860 that the first registry on paper of
pulse was accurately achieved by Dr. Marey in Paris as he described an improved sphygmograph
(3) (Figure 1-4). Nowadays, there is a whole array of readily available technology to evaluate the
different aspects of heart rate, such as various types of Holter monitoring, pacemakers,
implantable cardiac defibrillators, etc. Complex heart rate parameters are flot only evaluated at
rest, but during exercise as well.
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Figure 1-3.Original engraving ofthe 1628 Frankfurt edition.
61.3 Rationale for the study of the association between heart rate and mortatity.
There are some epidemiological population-based studies which have addressed the issue ofRHR
and mortality (4-13). There are also several studies relating heart rate during exercise and
prognosis using parameters such as heart rate recovery (HRRec), maximal heart rate (HRMax),
percentage of heart rate reserve (%HRRes) or other similar chronotropic response indices as
predictors ofcardiovascular events and mortality (14-24). However, these studies were performed
mostly in healthy individuals and it is of great interest to further explore the relationship of heart
rate and mortality in patients with coronary artery disease.
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Figure 1-4. Medical Instruments & Apparatus: Marey sphygmograph apparatus. Wood
engraving. Courtesy of the National Library of Medicine
71.3.1 Phylogenetic perspective
The ratio of heat loss (a function of body surface area) to heat production (a function of body
mass) increases with smaHer body size in mammals. This is the basic principle behind the
knowledge that smaller mammals have higher heart rates and shorter life spans than larger ones.
From a phylogenetic point of view a landmark study was published by Levine et ai, illustrating
that among mammals there is an inverse semilogarithmic relationship between heart rate and life
expectancy (25). This equation however, exciudes humans (Figure 1-5). There are a few
hypotheses to explain why humans escape from this relationship; nevertheless it is reasonable to
attribute this in part to advances in medical sciences and socio-economical development.
Conversely, the number of heartbeats in a lifetirne is remarkably constant despite a 40-fold
difference in life expectancy (25) (Figure 1 -6). The noticeable inverse relation between life span
and heart rate may reflect an epiphenomenon in which heart rate is a marker of metabolic
consumption.
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Figure 1-5. Semilogarithmic relation between rest heart rate and life expectancy in mammals.
Most coordinates represent average values. From Levine HJ. Rest heart rate and life expectancy.
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Furthermore, Azbel et ai, in a mathematical essay, provides some insight into this
mechanism(26). Drawing from a wide allometric scale of 1020-fold among living organisms, he
conciudes that the energy consumption/body atom per heartbeat is the same (within an order of
magnitude) in ail animais. Experimentai data verify this for dozens of species in ail taxes, from
invertebrates to mammals, and even for oxygen-consuming bacteria. The mean deviation is only
1.7 oxygen molecules per body atom larger or smaller than the average (27). Therefore, energy
expenditure seems constant in ail animais and RHR is directly involved in energy production
mainly in a regulatory fashion. Hence, there is a phylogenetic rationale for looking at this
relationship.
91.3.2 Molecular perspective
The ideas exposed above lead to a discussion of the molecular perspective. In the heart,
adenosine triphosphate (ATP) is synthesized by mitochondria from a variety of aerobic
substrates. ATP is generated from -oxidation of lipids (60-70%) and from carbohydrates
including exogenous glucose and lactate. Approximately 60-70% of total ATP is used for
contraction, incÏuding Ca re-uptake by the sarcoplasmic reticulum and extrusion of Ca to the
cytoplasm via the sarcolemmal Na/Ca and Ca pump. It follows that each heartbeat lias its
own cost: 1.35 x 1019 Ca ions have to be mobilized and approximately 300 mg ofATP are used.
Thus, the heart produces and utilizes approximately 30 Kg of ATP eacli day, and siowing its rate
by 10 heartbeats/min would resuit in saving of about 5 Kg of ATP in a day and its oxidative
stress byproducts (28).
1.3.3 Pathological perspective
Direct evidence of the importance of RHR on the progression of coronary atherosclerosis cornes
from animal studies. Beere et al reported that lowering heart rate by sinoatrial node ablation
retarded diet-induced atherosclerosis in primates (29). The development of coronary
atherosclerosis was analysed in three groups of cynomolgus monkeys: one control group, one
group that underwent sinus node ablation and one group that underwent a sham operation. All
animals received an atherogenic diet for 6 months. Atherosclerosis severity at the end of the
study in monkeys with a high RHR, was twice than in monkeys with a low RHR (mean
percentage stenosis 56 ± 23% vs. 26 ± 19%, mean plaque area 0.48 ± 0.47 mm2 vs. 0.21 ± 0.39
mm2) These differences were statistically significant despite similar blood pressure, serum lipid
levels and body weight. Furthermore, Kaplan et al have shown that monkeys with spontaneously
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high RHR have twice the extent of lesions in the coronary arteries as animais with Ïow RHR,
when fed a diet moderately high in saturated fats and cholesteroi for a period of 22 months (30).
This association between RHR and atherosclerosis was also studied in liumans. Perski et al have
observed, in a small group of young patients after myocardial infarction, that minimum and
average heart rate measured by a 24-h ECG are strongly related (r 0.70, p <0.002 and r = 0.59
p, < 0.01 respectively) to the severity of coronary atherosclerosis. This association was found
even after correcting for several established risk factors such as smoking habits, blood pressure,
body mass index (BMI) and serum lipoprotein concentrations (31). The same authors then
performed a more complete and larger study. The relations of hemodynamic factors, plasma
fibrinogen concentration, serum lipoprotein levels, and clinical risk indicators with CAD were
studied in 56 men who had survived a first myocardial infarction before the age of 45 and who
subsequently underwent two coronary angiograms with an intervening interval of 4 to 7 years
(32). High mean RHR measured during a 24-hour period was associated with progression of
diffuse lesions (r=0.34; p <0.05) and distinct stenosis (r=0.43; p <0.01). A high RHR also
correlated positively with progression of angiographie score of the global severity of coronary
atherosclerosis (r=0.36; p <0.01). In this study an increase in the RHR of 5 beats/min
corresponded to an increase in global atherosclerosis progression score of 0.21 (95% confidence
interval 0.17-0.24). Progression of disease was predicted independently by minimum heart rate
and low-density lipoprotein!high-density tipoprotein ratio. In contrast, lipoprotein A, fibrinogen
level, hypertension, smoking, and beta-adrenergic receptor blockade treatment did not
discriminate between patients with and without progression. In a retrospective study, Heidland et
al analyzed 106 patients who undenvent 2 coronary angiograms within 6 months (33). They
investigated 53 patients with initially smooth stenoses who developed plaque disruption by the
time of the second coronary angiogram and compared these patients with 53 age- and sex
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matched individuals with srnooth stenoses without angiographic signs of plaque disruption.
Logistic regression analysis identified positive associations between plaque disruption and both
lefi ventricular muscle mass >270 g and a mean heart rate >80 bpm and a negative association
with the use ofbeta-blockers.
1.3.4 CIinical perspective
Epidemiological studies have shown that, among patients without known heart disease, elevated
RHR is related to increased risk of all-cause, CV and sudden cardiac death. Additional indirect
evidence of the relationship between RHR and mortality corne from studies evaluating the effects
of f3-adrenergic receptor antagonists. The relationship between reduction in heart rate and a
decrease in rnortality has been weIl established with beta-blockers after myocardial infarction and
in patients with heart failure (34-37). When 3-blockers were classified according to their
pharmacological properties, those with intrinsic sympathomimetic activity appeared to have
reduced efficacy in comparison to those without such an activity. The capacity ofbeta-blockers to
reduce heart rate might therefore be an important determinant of their cardioprotective effect. The
relationship between heart rate slowing and reduction in clinical events is not restricted to beta
blocker therapy. In the Grupo de Estudio de la Sobrevida en la Insuficiencia Cardfaca en
Argentina (GESTCA) study, a decrease in mortality was observed in a subgroup of congestive
heart failure (CHF) patients with elevated resting heart rate (>90 beats/min) when treated with
amiodarone (38). This beneficial heart rate siowing effect of amiodarone was independent of the
patients’ arrhythmic profile. On the other hand, calcium channel blockers which lower RHR
(mainÏy diltiazem and verapamil) have been shown to slightly decrease the risk ofdeath and non-
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fatal reinfarction in survivors of acute rnyocardial infarction without clinical heart failure or
impaired left ventricular function (39, 40).
Heart rate has been also related to insulin sensitivity and insulin secretion in non-diabetic
patients. lii a multiple regression analysis (adjusting for age, sex, ethnicity, glucose tolerance
status and smoking), heart rate was significantly and independently associated with acute insulin
response to glucose, proinsulin and insulin sensitivity in non-diabetic individuals (41). The
relation between heart rate and lipid levels has also been studied (42). In both sexes, there was a
progressive increase in age-adjusted levels of total cholesterol, non-high density lipoprotein
(HDL) cholesterol and triglycerides and a decrease in HDL cholesterol with increasing heart
rates. The associations remained significant when anthropometric and life-style factors were
controlled for in the statistical analyses. These findings support the conception that RHR in itself
is linked to clinical events.
1.3.5 Genetic perspective
The interaction between RHR and sunrival may also have a genetic basis. A cohort of> 1000
individuals of Chinese and Japanese descent was genotyped for two polymorphisms, resulting in
a serine/glycine substitution at amino acid 49 (Ser49Gly) and an arginine/glycine substitution at
residue 389 (Arg389Gly), in the beta-1 adrenergic receptor (43). 13-1 polymorphism has been
associated with many cardiovascular disorders such as hypertension and others. for comparison,
polymorphisms in the beta2 and beta3 adrenergic receptors were also evaluated. The Ser49Gly
polymorphism was significantly associated (P=0.0004) with resting heart rate, independent of
other variables, such as body-mass index, age, sex, etlmicity, exercise, smoking, alcohol intake,
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hypertension status, and treatment with beta blockers. The data support an additive model in
which individuals heterozygous for the Ser49Gly polymorphism had mean heart rates
intermediate to those of either type of homozygotes, with Ser homozygotes having the highest
mean heart rate and with Gly homozygotes having the lowest. 73.8% of patients were Ser
homozygous, 23.5% were Ser49Gly heterozygous and 2.7% were Gly homozygous. Neither the
Arg389Gly polymorphism in the betal adrenergic receptor nor polymorphisms in the beta2 and
beta3 adrenergic receptors were associated with RHR. The authors estimated the heritability of
RHR at 39.7% (p < 0.00 1), which is similar to the one reported from the Framingham population
(44). Wilk et al performed a genome scan for quantitative trait loci (QTL) influencing the resting
heart rate among 962 Caucasians and 1124 African-Americans in the Hypertension Genetic
Epidemiology Network (HyperGEN), a multi-center study of genetic and environmental factors
related to hypertension (16). Within each race and sex, heart rate was adjusted for covariates,
including age, study center, body mass index, beta-blocker use, alcohol consumption, smoking,
number of blocks walked per day, and number of hours watching television. The evidence for
linkage found on chromosome 4 in both Caucasian and African-American hypertensive sib pairs
indicates that further investigation on that region may be warranted to locate a gene influencing
RHR (16). Martin et al (45) estimated the heritability of REIR on chromosome 4q in healthy
humans. This signal is in the same region as a QTL for long QT syndrome 4 and a QTL for heart
rate in rats (45). furthermore, QTL for heart rate have also been identified in drosophila (46) and
mice (47). Nevertheless, most of animal and human studies were done in hypertensive
populations and further work in this area and in different populations is therefore needed.
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1.3.6 Previous epidemiological studies assessing this relationship
The robust relationship between resting heart rate and cardiovascular events has been
documented in numerous epidemiological studies generally involving healthy populations. (4-6,
9, 11, 12) (Table 1-I). Four studies included only men (8, 10, 48, 49). In addition, Palatini et aï
(50-55) have examined the association between RHR and all-cause and cardiovascular mortality
in different populations and reported a positive relationship between tachycardia and mortality in
women, in patients with hypertension, with metabolic syndrome and also in elderly patients.
However, this association has neyer been studied in an unselected population of patients with
suspected or confirmed CAD.
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Table 1-I. Epidemiologic studies assessing RHR and total or CV mortality.
Author [StudyJ Entry Sample Years of Heart rate Study outcorne
(reference) year size Gender J age foflow-up measurement RR or HR (95%CI)
Kannel 194$ 5 070 Menlwomen 36 Supine ECG CVD3 rate p<O.00l
[Framingham] 35_94
(4)
Reunanen (5) 1966 10 717 Men/women 23 ECG Men” >84 bpmRR 1.40 (1.11-
30-59 1.77) Women’’ >94 bpm RR
1.40 (1.00-1.96)
Mensink 1982 4 756 Men1women 12 Radial pulse x 2 Menc HR 1.7 (1.2-2.6)
ISpandau] (6) 40-80 Womenc HR 1.3 (0.9-2.0)
Benetos (9) 1974 19 386 Meni’women 1$ Supine ECG Men” RR 2.18 (1.37-3.47)
40-69 Womend RR 1.46 (0.64-3.33)
Dryer [Chicago 1958 1 233 Mea 40-59 15 ECG Alla cause mortality rate
People GasJ (13) p <0.00 1
Dryer [Chicago 1957 1 899 Men 40-55 17 Radial pulse AW’ cause rnortality rate
Western p<O.00l
ElectricJ (13)
Dryer [Chicago 1967 33 781 Men/women 22 ECG Alla cause mortality rate
Heart 18-74 p<O.00l
Associationj (13)
GiIlum 1971 6 672 Men/women 10 Radial pulse Mene RR 1.44 (1.08-1.92)
INHANES IJ (12) 25-74 Womene RR 1.26 (0.89-1.76)
Seccareccia 1984 2 533 Men 40-69 4-13 ECG CVDHR 2.54 (1.25-5.16)
[MATISSJ (10)
Jouven [Paris 1967 7 079 Mea 42-53 23 Radial pulse death RR 1.28 (1.06-
Prospective 1.61)
Study 1] (7)
Kristal-Boneh 1985 3 527 Men mean age $ ECG CVD” RR 2.02 (1.1-4.0)
[CORDISJ (49) 43
Fujïura (8) 1977 573 Men 40-64 18 ECG Ail’ cause mortality HR 3.71
(1.35-10.22)
Bpm=beats per minute, C1= confidence interval, CVDcardiovascular death, ECG=elecfrocardïogram, HR=hazard
ratio, RR=relative risk.
a ANOVA. Highest heart rate quintile compared to lowest, age adjusted.
b CVD, age adjusted
C CVD adjusted for age, semm cholesterol, body mass index, systolic blood pressure, smoking and diabetes.
d CVD in highest heart rate qumtile compared to lowest adjusted for age, hypertension, previous myocardial
infarction, antihypertensive treatment, total choiesterol, physical activity and tobacco consumption.
e CVD data adjusted for age, smoking, blood pressure, cholesterol and other confounders, for heart rate >84
bpm in comparison with subjects with >74 bpm.
f >90 bpm compared to <60 bpm adjusted for age, systolic biood pressure, serum cholesterol, smoking, body
mass index, arm cfrcumference, forced expiratory volume, diabetes and preexisting cardiovascular disease.
g highest heart rate quintile compared to iowest, adjusted for age, body mass index, systolic biood pressure,
tobacco consumption, parental lustory of myocardial infarction and sudden death, cholesterol level, diabetes and
recreational activity.
h >90 bpm compared with <70 bpm adjusted for age, recreational acfivity, systolic blood pressure and low
density lipoproteins.
>90 bpm compared with <70 bpm adjusted for age, diastolic biood pressure, serum choiesterol, uric acid
and antihypertensive medication.
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1.4 Pathophysiology of the association between heart rate and cardiovascular events.
1.4.1 Autonomic imbalance.
One of the most interesting aspects of recent analyses in cardiovascular epidemiologic studies is
the realization that increased RHR is frequently associated with high blood pressure, obesity,
insulin resistance, dyslipidemia, and elevated hematocrit (41, 51, 56, 57). Syrnpathetic
overstimulation could explain the interrelationship between the above risk factors and heart rate.
In animal models, chronic 3-adrenergic stimulation causes conversion from a small to a larger
proportion of insulin-resistant fast twitch muscle fibers. Acute adrenergic receptor-mediated
vasoconstriction shunts the nutritional blood flow away from the active glucose-metabolizing
celis in the skeletaÏ muscles, decreasing the ability of these celis to utilize glucose, adding another
important factor in the insulin resistance scenario (56). Jncreased plasma insulin and insulin
resistance are in epidemiologic studies associated with dyslipidemias and the mechanisms by
which high insulin could cause dyslipidemias have been described (58, 59). Facchini et al found
that insulin resistant individuals, with compensatory hyperinsulinemia, have a higher noctumal
heart rate (60). Patients with sympathetic overstimulation have higher hematocrit. An elevated
hematocrit is associated with an increased risk of coronary morbidity as well (61).
When markers of vagal tone are reduced, the risk of death is increased. This has been
demonstrated for baroreflex sensitivity, heart rate variability, heart rate turbulance (T-wave
alternans) and heart rate recovery afier exercise. This last parameter has been proven to be
independent of the severtiy of coronary artery disease, suggesting alternative mechanisms (17).
Jouven et al followed 5 713 healthy men for 23 years (24). $ubjects with a decrease in heart rate
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1.4.2 Tachycardia as an independent mechanism of risk for mortality.
The intensification of the pulsatile nature of the arterial blood flow associated with tachycardia
may favor the occurrence of injury to the endothelium (62-64). Also, in the natural history of
CAD, plaque destabilization and rupture are key phenomena that ofien lead to clinical events. In
addition to the link between RIIR and atherosclerosis progression that we have already described,
the higher number of repeated small stresses on a potentially vulnerable atherosclerotic plaque
recovery after exercise had a relative risk of 2.20 (95% CI 1.04-4.74) for sudden death,
suggesting an increased risk for fatal anhythmias in this population.
Figure 1.7. Autonomic imbalance and CV events.
1$
may increase the likelihood of rupture because of the well-known concept of fatigue of a
biomaterial (65).
As presented above, there are epidemiological, physiological, metabolic, phylogenetic,
molecular, clinical and genetic reasons to further study and explore the relationship between
RHR and prognosis.
1.5 Heart rate and exercise
The use ofexercise stress testing as a means ofcardiac evaluation has developed slowly over this
century. Progressive exercise is viewed nowadays as a method of physiologic evaluation since it
provides an index of maximal oxygen uptake or aerobic capacity, which is in itself correlated
with heart rate at submaximal exercise. Although exercise stress testing continues to be
predominantly used for screening and management of coronary artery disease, it is also valuable
in many other cardiovascular settings such as congestive heart failure, cardiovascular fitness,
exercise-induced arrhythmias, valvular heart diseases and the evaluation of chronotropic
response. Over the past years, exercise treadmili testing (ETT) has become more of a predictive
than a diagnostic tool (66). The huge number of patients in a variety of settings who have
undergone an ETT, made it possible to successfully identify powerful markers of risk. The
performance of different heart rate parameters during ETT has been extensively studied,
especially in healthy populations. In this thesis, I will attempt to further examine the application,
clinical relevance and added prognostic value of diverse heart rate parameters during ETT in a
population of patients referred for a coronary angiogram due to suspected or confirmed CAD. I
will focus on four measures that are routinely available in the vast majority of ETTs: maximal
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heart rate (ERmax), heart rate recovery (HRRec) age-predicted maximal heart rate (APMHR)
and finally percentage ofheart rate reserve (% HRRes).
1.5.1 Maximal heart rate during exercise treadmiil test
In the early 1970s Ellestad tested a 51-year-old athietic man who had anormal exercise tolerance
and no symptoms or ST-segment depression during exercise (67). A short time after the exercise
test, lie suffered sudden cardiac death and an autopsy revealed severe two-vessel coronary disease
with an 80% left anterior descending artery stenosis. 0f note, the patient had only reached a
maximum heart rate of 110 beats per minute during the ETT. Triggered by this episode, Ellestad
and his coïleagues examined a EIT database with 2 700 patients and found that those with a
blunted heart rate response were at greater risk for a cardiac event than those with ischemic SI
depression (6$). During the past two decades, exercise capacity, chronotropic incompetence and
activity status have become well-established predictors of cardiovascular and overail mortality
(21, 67-70). An impaired chronotropic response has been shown to be predictive of ah-cause
mortahity and risk of developing CAD, even afier accounting for age, physical fitness, standard
cardiovascular risk factors, left ventricular EF and myocardial ischemia (21, 23, 67, 71, 72).
Chronotropic incompetence could be an indicator for decreased heart rate variabihity, a
prognostically important manifestation of autonomic dysfttnction. In a recent article, Jouven et al
reported that patients with a HRmax <89 bpm have a 6.18 (2.37-16.11) relative risk ofsudden
death (24). Maximal heart rate during ETT lias its limitations since it is influenced by the
patient’s age and physical fitness. It is well known that age is one of the most important
determinants of the exercise heart rate response, with maximal peak heart rate dechining with
older age.
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1.5.2 Age-predicted maximal heart rate (APMHR)
APMHR is undoubtedly the most used chronotropic response measure in ETI laboratories
throughout the world. APMHR is calculated as: 220 minus age. The ACC/AHA 2002 guidelines
update for stress testing (73) defines chronotropic incompetence as the failure to achieve 85% of
APMHR. Nevertheless, the history and validation of this parameter is somewhat peculiar. Most
cardioÏogy and exercise physiology textbooks do not have an original citation for this 85% cutoff,
nor for the 220 minus age formula. A nicely written review of the history of the “HRmax=220-
age” was published in the Journal of Exercise Physiology (74). This formula was flot developed
from original research but rather was the result of the review of 11 references and unpublished
scientific compilations (74). Additionally, its standard deviation is quite high (Sxy=7-1 1 bpm).
Therefore, given the poor validation and scarce original research there is no solid scientific value
for the use of this formula in exercise physiology.
1.5.3 Heart rate recovery (HRRec)
HRRec is thought to be primarily a vagal phenomenon, and because decreased vagal activity is
associated with increased risk of death, a lot of attention has been paid to this measure. HRRec
has been found to be a strong marker of CV mortality and CV events flot only in healthy subjects
(20, 75) (both men and women) but in various populations, such as in elderly, diabetics, patients
with CHF, CAD, myocardial infarction and dyslipidemias (19, 20, 75-88).
Jouven et al recently reported a relative risk for sudden death of 2.20 (1.02-4.74) for patients with
insufficient HRRec. HRRec is computed as HRmax minus heart rate post-exercise (usually one,
two or three minutes after finishing exercise). There is no clear definition of when to take heart
rate after exercise. Most studies have used arbitrary times of 1 or 2 min. In our population
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evaluated in the mid 1970s, this concept had flot been tackled and heart rate was recorded 3
minutes after completion of the ETT. Other studies have found a predictive value of HRRec for
ail-cause death even when measured as long as 5 min afler recovery ($4). It is nevertheless
possible that heart rate parameters during the first 30 seconds after exercise may be more
informative (89). Additionally, there is no consensus on the normal value of HRRec. The most
common arbitrarily chosen value is more than 12 beats per min in 1 min. Only a few of the
studies on HRRec have been restricted to symptomatic patients without revascularization. The
population presented here is an unselected population of patients refened for coronary angiogram
due to suspected or proven CAD and will therefore provide new important information about this
parameter.
1.5.4 Percentage of heart rate reserve
The effects of age, physical fitness and resting heart rate confound previous measures of
chronotropic response to exercise. Wilkoff et al (14) first portrayed the mathematical relationship
that exists between heart rate and oxygen consumption and named it the metabolic chronotropic
relation. This mathematical model has been improved and describes the normal chronotropic
response during exercise as being primarily dependent on age, RHR and peak functional capacity.
The model shows that the %HRRes achieved during ETT is equivalent to the percentage of
metabolic reserve (%MR) achieved when normal aduits exercise on a treadmili. %HRRes equals
to ((HRstage — HRrest) / (220-age-HRrest)) x 100. Similarly, %MR equals ((METSstage — MET5rest) /
(METSpeak — MET5rest) x 100. Most importantly, this relationship holds true regardless of the
exercise protocol. All subjects exhibited a linear increase in %HRRes equal to the %MR.
Consequently, when these two terms are plotted with each other, a linear response with a slope of
1.0 and a y-intercept of 0.0 is achieved (14). The authors called this equation the chronotropic
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index. By using this formula, the heart rate achieved at any point of exercise can be classified as
consistent or inconsistent with normal chronotropic function (Figure 1-8).
100
60
%HR
60
Reserve
40
20
o
Figure 1-8. The metabolic chronotropic relation (MCR) is best characterized by the siope of the
une when % HRRes is plotted in relation to percentage metabolic reserve. Confidence interval
calculations of the siope on this une statistically define chronotropic competence. Shown here are
the 85%, 90% and 95% confidence interval MCR siopes (Wiikoff BL, Miller RE. Exercise
testing for chronotropic assessment. Cardiol Clin 1992;10(4):705-17)
In a group of healthy, nonhospitalized aduits studied by Wilkoff, the chronotropic index was
approximately 1 (95% CI 0.8-1.3) (14). Thus, chronotropic incompetence can be defined as a
%HRRes used to %MR used. A ratio of <0.8 is used to define a low chronotropic index. The
main advantages of using this approach are: (1) it is not reiated to functional capacity and
therefore is not elevated specificaiÏy among patients with a poor functional capacity; and (2) it is
not affected by exercise protocol or by which stage of exercise is used for measurement (14, 18).
Except for patients undergoing ETT with 02 consumption analysis, exercise capacity in METs is
estimated and flot directly measured. This could be a drawback in the application of this
parameter (18). Nevertheless, in the population studied in this thesis, ail patients underwent
symptom-limited testing (maximal exercise capacity). Therefore, the %HRRes used to metabolic
reserve used at peak exercise has a value of 1, as proposed by the iiterature (18). The use of
0 20 40 60 80 100
¼ Metabolic Reserve
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%HRRes has been validated by numerous studies and was found to be a good predictor of
mortality, independent ofother well known CV risk factors (14, 18, 21, 22, 71, 72, 90). Most of
these studies are based in relatively healthy individuals, and few of them have focused on more
clinically relevant populations such as patients referred to exercise testing for clinical reasons. As
it may be inferred, the population studied in this thesis is ideal to further explore, compare and
analyze the prognostic value of these different heart rate parameters during ETT. One main
disadvantage for the use of % HRRes achieved, as a measure of chronotropic insufficiency, is the
methodology used for choosing a normality value. For clinical purposes, it is sometimes
important to choose different cutoff points, especially when there is a wide range of values, or
when the clinical nuance is lost if analyzed as continuous variable. However, the methodology
for deciding the rnost appropriate cutoff points is cumbersome. Most authors, as proposed for %
HRRe5, use 95% confidence intervals for normal distribution. This raises a myriad of
methodologic and statistical issues. Therefore, when it is clinically and statistically feasible, it is
preferable to test the variable of interest in a continuous fashion, in order to eliminate these
methodological quandaries. Consequently, all heart rate parameters in this thesis were analyzed
as continuous variables.
1.6 General goals ofthis thesis and hypothesis to be tested.
The goals of this thesis are to study the prognostic value of resting heart rate and to explore the
relationship between different heart rate parameters during ETT and long-term and CV mortality
in a population of patients with CAD.
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To accomplish these goals, two independent original articles analyzing data from the Coronary
Artery Surgery $tudy (CA$S) are presented. In the first article, I hypothesized that the survival
time and time to CV events (CV death, rehospitalization due to any CV cause and
rehospitalization due to any of the following: myocardial infarction, angina, stroke or heart
failure) would decrease with increasing heart rate quintiles after correction for baseline risk
factors and other confounders. In the second article, the hypothesis was that the same end-points
would be affected by various heart rate parameters available during ETT. I will also determine
which of these heart measures during exercise contributes the most to clinical outcome in this
population of patients.
CHAPIER 2
METHODS
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2 METHODS
2.1.1 Database and study group description
The National Heart, Lung, and Blood Institute (NHLBI) sponsored the Coronary Artery Surgery
Study (CASS). CASS is a multi-institutionai research program consisting of a randomized trial of
the medical vs. surgical treatment of coronary artery disease and a sttbstantially larger registry of
patients undergoing diagnostic evaluation, inchtding coronary arteriography for the presence of
proven or suspected CAD. from August 1975 through May 1979, a total of 18 894 men and 6
065 women underwent coronary arteriography for proven or suspected CAD at one of the 15
participating sites. From this pool of patients, those meeting specific selection criteria were
randornized into medicai and surgicai treatment groups. This thesis will focus on ail patients in
the registry, and flot just the ones randomized to either medical or surgicai treatment. A detailed
description of CASS has been published (91) and oniy the most relevant and pertaining data wilÏ
be discussed here. Hereby, follows a general description of CASS. A more detaiied description of
the population selected for each ofthe articles is incÏuded in each article’s method section.
0f the eligible subjects, 4% declined to participate in the study and an additional 2% were flot
enrolled for a variety of reasons, such as medical emergency or unavailabiiity of study personnel
(Figure 2-1). The registry represents the population referred to each site for study and treatment
of coronary artery disease and is the source from which candidates for randomization were
identified. Clinical, laboratory and angiographic profiles were meticulously entered in a computer
assisted medical database, which is available at the Montreal Heart Jnstitute. The registry at each
participating center included ah patients whose primary indication for coronary angiography was
suspected or proven CAD.
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Figure 2-1. CASS patients flow diagram
Patients with normal coronary angiograms were also included in the registry. Patients studied
because of suspicion of CAD who were diagnosed to have another form of heart disease were
excluded from the registry. Sorne patients who underwent coronary angiography for evaluation of
other conditions, such as valvular disease, cardiomyopathies and congenitat heart disease, were
also excluded even if subsequent evidence showed that CAD was indeed a major clinical
problem. These patients were flot sent by their referring physician due to suspected or proven
CAD. This is clinically relevant, since the studied population consists of patients in whom there
was a clinical suspicion of CAD, this being a reflection of current practice and rendering the
resuÏts of CASS applicable to daily situations. Exclusion criteria for the registry consisted in the
following: 1) inaccessibility for follow-up, 2) substantial language barrier, 3) referral to a CASS
site expressly for surgery with coronary angiography performed elsewhere, 4) cardiomyopathy
flot due to ischemic heart disease, 5) idiopathic hypertrophic subaortic stenosis and 6) significant
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valvular heart disease. Patients with minimal regurgitation due to mitral valve prolapse were
included in the registry.
2.1.2 Informed consent
Enrolment was contingent upon obtaining the patient’s signed informed consent and it was
usually obtained before the initial index coronary angiographic study. Patients were told that data
collected would be used to evaluate the natural history of CAD and that they wouid therefore be
contacted annually for follow-up. Subjects have been assured that ah data are strictly confidentiai
and that only CASS research personnel have access to their records. Data obtained for the present
study was kept with the original encoding; therefore no personal information was obtained.
2.1.3 Baseline data collection and variables description
Basehine clinical and laboratory data on ail registry patients at participating clinical sites were
recorded in printed forms. These forms were transmitted within 8 weeks to the coordinating
center with strict quaiity control procedures. Variables included in this thesis wiil be in bold and
explained. These forms were:
a) Patient information form. Mainly demographic data. Age and sex at time of enrolment.
b) Health status questionnaire. A description of the type and severity of symptoms,
including a subjective evaluation of functionai limitations.
c) Patient history form. A review of risk factors, prior cardiovascular ilinesses, and other
medical problems. History of cigarette smoking was considered as presently smokes cigarettes
(at enrolment and tbree months before or after), formerly smoked cigarettes and neyer smoked
cigarettes. Recreational activity was assessed within the three months prior to enrolment and
was divided as strenuous Qhysically demanding recreational activity involving competition or
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endurance, including team efforts), moderate (activities performed for pleasure and relaxation
but without competition or endurance), mild (recreation carried out for pleasure and relaxation
and involving only slight physical activity) or sedentary. Any patient with a known past medical
history of diabetes (DM) was considered as diabetic at entry of enrolment. Hypertension (HTN)
was identified if there was a past medical history of hypertension, confirmed by a physician.
d) Present illness profile. This is an assessment of clinical manifestations of CAD, with
particular attention to the charactenstics and severity of angina pectoris and CHF and current
medical therapy within two months of enrolment. Medications included among others -blockers
(mainly propranolol), antiplatelets (aspirin or dipyridamole), digitalis, diuretics (furosemide,
ethacrynic acid, thiazides or aldactone), antihypertensive agents (except diuretics), Iipid
Iowering agents, and insulin therapy.
e) Physical examination and laboratory data form. These variables were vital signs, major
cardiovascular findings and laboratory data. Resting heart rate was measured by radial pulse
during 60 seconds with the patient in a sitting position. Body mass index (BMI) was calculated
as weight in kg divided by the square of height in meters. The hospital laboratories of the
cooperating clinics analyzed total cholestero] and triglyceride levels. Total cholesterol was
expressed in milligrams per deciliters.
f) Exercise treadmili test (ETT). All patients in the randomized study were required to
undergo a maximal ETT at the time of baseline evaluation, at 6 and 18 months afler actual or
scheduled surgical treatment, and at 60 months afler enrolment. Although exercise testing was
not mandatory for registry patients, it was encouraged and the resuits were recorded. They were
performed in motor-driven treadmili, according to the Bmce protocol. Any patient suspected of
having had a myocardial infarction within the preceding 6 weeks was routinely excluded from the
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test. for most patients, testing was begun at stage 1 (1.7 mph at 10% siope). Reasons for
discontinuing the test included the following: moderate or severe chest pain (3 or 4 on a scale of
4), classified as definitely angina, probably angina, probably not angina or definitely flot angina;
unsteady gait; hypotension (a 20-mmHg drop in systolic blood pressure from the highest
preceding value); ventricular arrhythmia, including ventricular tachycardia or ventricular
fibrillation, coupled or frequent multifocal ventricular premature complexes or new ventricular
bigeminy; rapid supraventricular arrhythrnias; symptoms (e.g, chest pain, dizziness, dyspnea,
near syncope, lower extremity claudication, fatigue or weakness, and poor motivation). Patients
were questioned at the time of ETT whether they were taking medication that might affect the
test’s resuits. Among other medications, the ones affecting heart rate behavior were selected. It
was registered whether the patient was either taking -b1ockers (within 24 hrs) or digitalis
(within 7 days). Heart rate during exercise was recorded three times. Baseline heart rate was
measured in a sitting position, before the start of ETT. Maximal heart rate was registered at
maximal exercise with the patient in standing position. Post-exercise heart rate was measured 3
minutes afler ending of ETT with the patient in the sitting position, without any “cool-down”
phase.
g) Chest x-ray and coronary angiography form. AIl sites measured the same variables in
the same order and use the same nomenclature to describe left ventricular wall motion and
coronary artery anatomy. A detailed description of the standard angiographic procedure has been
published elsewhere (91). Coronary vasculature was divided in 18 numbered segments (Figure 2-
2). Segments coded as anatomically absent were excluded. Dominance was considered in the
assignment of individual segments to a particular major coronary artery distribution. The
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maximum stenosis in % of lumen diameter was freely assigned (rather than fixed to a
prespecified % stenosis range) by CASS-certified, clinical site angiographers in relation to an
appropriate adjacent reference diameter. The estimated percentage of obstruction was derived
from the angiographic view showing the greatest reduction in diameter for the vessel in question.
Inter-reader variability in assessing segment stenosis in CASS had previously been reported, with
a ic-statistic for between readers variability of 0.66 (0.33-0.86) for ah segments and 0.77 (0.65-
0.86) when only proximal and mid segments ofthe major coronary vesseis were considered.
Figure 2-2. Terminology for coronary artery anatomy visualized at angiography utilized by cooperating sites in
CASS. (1) proximal right; (2) mid-right; (3) distal right; (4) right posterior descending; (5) right posterior lateral
segment; (6) first right posterior lateral; (7) second right posterior lateral; (8) third right posterior lateral; (9) inferior
septal; (10) acute marginaI; (11) lefi main; (12) proximal left anterior descending; (13) mid-left anterior descending;
(14) distal left antenor descending; (15) first diagonal; (16) second diagonal; (17) first septal; (18) proximal
circumflex; (19) distal circumflex; (20) first obtuse marginal; (21) second obtuse marginal; (22) thfrd obtuse
marginaI; (23) lefi atrio-ventricular; (24) first lefi posterior lateral; (25) second left posterior lateral; (26) third left
posterior lateral; (27) left posterior descending. From National Heart, Lung, and Blood Insfitute Coronary Artery
Surgery Study. A multicenter comparison of the effects of randomized medical and surgical treatment of mildly
symptomatic patients with coronary artery disease, and a registry of consecutive patients undergoing coronary
angiography. Circulation 1981 ;63(6 Pt 2) :11-81
The mean absolute deviation of coronary stenosis ranged from 1.8% to 9.4% in 870 randomly
selected abnormal cine films (92). The criterion for chinically significant coronary artery
obstruction is either 70% or more reduction in the internal diameter of the right coronary (RC),
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lefi anterior descending (LAD) or left circumilex (LCx) coronary artery or 50% or more
reduction in the internai diameter of the lefi main coronary artery (LMCA). The extent of CAD is
defined as follows: In the presence of right dominant circulation, the three major branches
involved in the one-, two- and three-vessel disease classification are the right anterior descending,
LAD and LCx arteries respectively. In the case of a left-dominant circulation, they are the LAD,
the proximal LCx artery and its marginal branches, and the distal LCx artery and its
posterolateral branches. The nomenclature in the case of a baianced circulation is the same as that
used to describe a right dominant circulation. A patient with 50% or greater obstruction of the lefi
main coronary artery is classified as having two-vessei disease if the circulation is right-dominant
and three-vessel disease if it is left-dominant.
h) Left ventriculography form. This was done with standardized procedure, projections
and measurements. The left ventricular end-systolic volume (ESV), end-diastolic volume (EDV),
and ejection fraction (EF) were caiculated using a single-plane adaptation of the area-iength
method ofDodge and co-workers(93). Ef vas caiculated as
EDV-ESV
EDV
Ail these forms are available at the Montreal Heart Institute Coordination Center (MHICC).
2.1.4 Patients follow-up
The date of enrolment was that of the initial angiographic evaluation. Annual clinical follow-up
was mandatory for ail patients in the registry. Additional information was obtained for ail
patients in the registry who suffered a “coronary event”. CASS follow-up requirements for
various situations designated as “coronary events” included the following:
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(A) If a patient experienced a myocardial infarction, ail relevant information, including
electrocardiograms (ECGs) and the resuits of enzyme studies, were obtained regardless of
whether the patient was hospitalized.
(B) Detailed reports of hospitalizations for any cardiac event or stroke were collected if the
period ofhospitalization exceeded 5 days.
(C) If a patient was hospitalized for coronary angiography or cardiac surgery, a specific
description of the hospitalization and the procedures performed was obtained.
(D) If a patient died, a detailed report of the circumstances of death was fihled out.
Patients were followed aimually through 1982 and thereafter by a final mail survey between 198$
and 1991 to which 94% responded. Vital status among non-responders at last foilow-up was
obtained through 1991 from the National Death Index and, in some cases, from next of km such
that the status of 95.8% of ail CASS patients was known. Median duration of follow-up (and
interquartile range) was 14.7 (9.0-16.1) years.
2.2 Statistical analysis
2.2.1 Variable selection and treatment
Variables for this thesis were chosen according to literature review, clinical relevance and data
availability. Resting heart rate was analyzed both as a continuous and as a categoricai variable.
Nonetheless, it seemed clinicaily more appropriate to present it divided by quintiles. These
quintiles were based once again according to literature review and to our population’s distribution
(94). It was flot the intention of this research project to find a threshold or cutoff variable
separating “normal” from “abnormal” subjects. Ail heart rate measurements during ETT were
kept as continuous variables, without any recoding. Solely for the purpose of baseline data
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presentation and in an effort to harmonize with previous studies patients, were classified
according to their chronotropic incompetence status. Chronotropic incompetence was defined as
either failure to reach 85% of APMHR andlor < 80% HRRes, because these are the two most
widely used definitions. Once again, it was not the purpose of this study to find normal values for
heart rate measurements during ETT. The choice of a “normal” threshold in medical science is
difficuit; it cannot be simply based on the 95% confidence interval of a normal distribution and
much more complex statistical methods have been proposed (95, 96). Table 2-I displays in
further detail the definition of each variable.
35
Table 2-I. List of variables.
Variable Definition
Age At baseline or at ETT
Gender Male I Female
Resting heart rate Obtained manually from radial pulse during 60 seconds at baseline or at ETT with the
patient in a sitting position
Maximal heart rate from ECG at peak exercise
during ETT (HRMax)
Heart rate recovery Maximal heart rate during exercise minus post-exercise heart rate without cool-down
(HRRec) period, 3 min after a modified Bmce protocol
% ofheart rate reserve ((Maximal heart rate —heart rate at rest) / (220— age —heart rate at rest)) x 100
(%HRRes)
Metabolic equivalents Fstimated by the total time compïeted in the final stage, speed and siope oftreadmill.
(METS)
ST abnormality at peak 1 mm of horizontal or downsloping ST-segment depression> 80 ms after die J point or
exercise if there vas I mm of additional ST-segment elevation in leads without pathologic Q
waves
Ef Single-plane area-length method. Ef: EDV — ESV
EDV
Use of-blockers At baseline or at ETT
Hypertension History of hypertension, confirmed by a physician.
Diabetes mellitus History ofdiabetes mellitus, confirmed by a physician
Cholesterol level Expressed in milligrams per decilitres
BMI Weight in kg divided by the square ofheight in meters
Smoking status Within 3 months prior to or after enrolment. Presently, formerly or neyer smoked
cigarettes
NCDV According to CAS S criteria
Recreational activity At baseline. Strenuous, moderate, mild or sedentary
Antiplatelet therapy At baseline, mainly ASA or dipyridamole
Diuretics At baseline, mainly furosemide or hydrochiorothiazide
Lipid-lowenng drugs At baseline
Total mortality Vital status obtained from FU forms, final survey and NDI records
CV mortality Cause of death if known, obtained from FU forms, fmal survey and NDI records. CV
death included cardiac direct, cardiac confributrny and sudden unexplained death
Rehospitalizations due to Ever hospitalised for MI, angina, stroke, CHF, revascularization or rhythm disturbance
CV cause
MI Ever hospitalised for MI, diagnosis based on ECG andJor enzyme analysis
Angina Ever hospitalised for angina or chest pain for more than 5 days
Stroke Ever hospitalised for stroke or transient ischemic affack
CHF Ever hospitalised for CHF for more than S days
ASA=aspirin; BMI=body mass index; CASS=Coronary Artery Surgery Study; CHf=congestive heart failure; CV=cardiovascutar;
ECG=electrocardiogram EDV=end-diastolic volume; Efejection fraction; ESV=end-systolic volume; ETF = exercise treadmiil test; fU=follow
up; MI=myocardial infarction; NCVD=number of diseased coronaiy vessels; NDI=National Death Index; RHR=resting heart rate.
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2.2.2 Descriptive statistics
for the purpose of data presentation bivariate analyses were performed in order to compare
patients within different RHR quintiles and patients with or without clwonotropic incompetence.
For categorical variables, a test was performed. When comparing continuous variables
between patients with and without chronotropic incompetence, t-tests were used. Likewise, when
comparing different RHR quintiles one-way ANOVA analysis was performed.
2.2.3 Survival analysis
In both articles, the dependent variable is time to an event (total or CV mortality,
rehospitalization due to CV cause). Independent variables are variables at baseline, risk factors
and different heart rate pararneters. Cox proportional hazards (PH) regression models were used.
Correlations between independent variables were checked on a correlation matrix. When high
correlation was found, clinical judgment was implemented to choose the most appropriate
variable to be included in the model. To further select the variables to be incorporated in a
multivariate model, univariate Cox PH regression analysis were first conducted and variables
with a p value <0.25 were chosen to be included. Some variables were forced into the model,
according to their clinical relevance. The proportional hazard assumption for the Cox model was
tested graphically with a Ïog-log plot for categorical and Schoenfeld’s residuals plot for
continuous variables. Linearity assumption was assessed by log transformation of each
continuous variable and graphical testing against survival time. Results were expressed in hazard
ratios for Cox PH model. Because of the large number of patients and variables included in the
first article, we used two-tailed significance level of 0.01 and 99% confidence interval (CI). For
the second article the significance level was set to 0.05 with 95% CI. For this same article, once
Cox PH models that were most predictive of total and CV mortality were determined, different
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exercise heart rate parameters and exercise capacity in METS were independently added to each
Cox PH mode! to detemiine the incremental value of each parameter using the Wald test (97, 98).
The parameter with the largest Wald test value was considered the one adding the most
information to the model. Ail analyses were performed with SPSS v.12 for windows (SPSS 1nc,
Chicago, Illinois). Further details about statistical analyses can be found in each article methods
section.
oCHAPTER 3
n
ORIGINAL ARTICLE NUMBER ONE
n
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Abstract
Background: Heart rate reduction is the cornerstone of the treatment of angina. The prognostic
value ofheart rate in patients with stable coronary artery disease (CAD) is not known.
Methods: We assessed the relationship between resting heart rate at baseline and cardiovascular
mortality/morbidity while adjusting for risk factors. A total of 24913 patients with suspected or
proven CAD from the Coronary Artery Surgery Study (CAS S) registry were studied for a median
follow-up of 14.7 years.
Resuits: Ah-cause and cardiovascular mortality and cardiovascular rehospitalizations were
increased with increasing heart rate (P<0.0001). Patients with resting heart rate ?: 83 bprn at
baseline had a significantly higher risk for total mortahity (hazard ratio =1.32, CI: 1.19-f .47,
P<0.0001) and cardiovascular mortahity (hazard ratio =1.31, CI: 1.15-1.48, P<0.0001) after
adjustment for multiple clinical variables when compared to the reference group. When
comparing patients with heart rates between 77-82 bpm and $3 bpm to patients with a heart rate
62 bpm, the hazard ratio for time to first cardiovascular rehospitalization were 1.11 and 1.14
(P<0.001 for both).
Conclusion: Resting heart rate is a simple measurement with prognostic implications. High
resting heart rate is predictor for total and cardiovascular mortality independent of other risk
factors in patients with CAD.
Keywords: high resting heart rate, prognosis, coronary heart disease, mortality, cardiovascular
mortality, rehospitalizations.
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Introduction
The total number ofheartbeats in a lifetime remains fairly constant across species and there exists
an inverse relationship between resting heart rate and life expectancy [1]. Epidemiological
studies have addressed the issue of the importance of heart rate in healthy humans [2-12]. The
association between resting heart rate and mortality has been observed in patients with
hypertension, with metabolic syndrome and in the elderly [13-1$]. However, there is littie
information on the prognostic value of resting heart rate in patients with stable coronary artery
disease (CAD).
Although heart rate reduction is helpful in preventing angina, it is not clear whether a lower heart
rate is associated with a more favorable prognosis in patients with CAD. This question is
clinically important because it may support the relevance of testing the effect of lowering heart
rate to reduce cardiovascular rnortality and morbidity. Experimental and clinical studies have
already suggested that heart rate reduction may improve coronary endothelial function and
atherosclerosis [19-29]. The objective of the present study was to evaluate the relationship
between resting heart rate and future cardiovascular events in a large population of patients with
suspected or proven CAD with an extended follow-up.
METHODS
The Coronary Artery Surgery Study (CA$S) was a multi-center research program consisting of a
randomized trial of medical vs. surgical therapy and a large registry of patients undergoing
coronary arteriography for the presence of suspected or proven CAD. From August 1975 through
May 1979, a total of 1$894 men and 6065 wornen undenvent coronary arteriography at one ofthe
15 participating sites (total number of patients: 24959). From this pool of patients, those meeting
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specific selection criteria were randomized into medical and surgical treatment groups. This
study focuses on ail patients included in the registry. A detailed description of CASS has been
published elsewhere [30]. The registry at each participating center included ail patients whose
primary indication for coronary angiography was suspected or proven CAD. Patients studied
because of suspicion of CAD who were diagnosed to have another form of heart disease were
excluded from the registry. Some patients who underwent coronary angiography for evaluation
of other conditions, such as valvular disease, cardiomyopathies and congenital heart disease, were
aiso excluded even if subsequent evidence showed that CAD was indeed a major clinicai probiem
because they had flot been referred for suspected or proven CAD. Exclusion criteria for the
registry consisted of the foliowing: 1) inaccessibiiity for follow-up; 2) substantial language
barrier; 3) referral to a CASS site expressiy for surgery with coronary angiography perfonued
elsewhere; 4) cardiomyopathy flot due to iscliemic heart disease; 5) idiopathic hypertrophic
subaortic stenosis and 6) significant valvular heart disease. Patients with minimal regurgitation
due to mitral valve prolapse were inciuded in the registry. Enrolment was contingent upon
obtaining the patient’s written informed consent and it was usually obtained before the initial
index coronary angiogram. Baseline resting heart rate was obtained manuaiiy at enrolment with
radial pulse measurement during 60 seconds. The variables evaluated in CASS have been
previously described in details [30]. Variables for the current study were chosen based on
previous literature, data avaiiability and clinical relevance (Table 3-I).
Patient follow-up
The date of enrolment was that of the initial angiographic evaluation. Annual ciinicai follow-up
was mandatory for ail patients in the registry. Additional information was obtained for ail
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patients in the registry who suffered a “coronary event”. Coronary Artery Surgery Study
follow-up requirements for various situations designated as “coronary events” included the
following:
(A) If a patient experienced a myocardiai infarction (MI), ail relevant information, including
electrocardiograms (ECGs) and the resuits of enzyme studies, were obtained regardless of
whether the patient was hospitalized.
(B) Detailed reports of hospitalizations for any cardiac event or stroke were collected if the
period of hospitalization exceeded 5 days.
(C) If a patient was hospitalized for coronary angiography or cardiac surgery, a specific
description ofthe hospitalization and the procedures performed was obtained.
(D) If a patient died, a detailed report of the circurnstances of death was fihled out.
Patients were followed annually through 1982 and thereafter by a final mail survey
between 198$ and 1991 to which 94% responded. Vital status among non-responders
at last follow-up was obtained through 1991 ftom the National Death Index and, in
some cases, from next of km such that the status of 95.8% of ail CASS patients was
known. Median duration of follow-up (and interquartile range) was 14.7 years ( 9.0-
16.1 years).
Statistical methods
In order to summarize the independent variables and to better understand their relationship to
heart rate, descriptive statistics are presented by heart rate quintiles. Quintiles were chosen
according to the resting heart rate distribution in the general sample population:
heart rate 1=62 bpm, heart rate 2=63-70 bpm, heart rate 3=71-76 bpm, heart rate 4=77-82 bpm
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and heart rate 5=?:83 bpm. for the purpose of data presentation, heart rate quintiles are compared
using the chi-square test for categoricai variables and one-way ANOVA for continuous variables.
Risk factors or covariates were chosen based on their clinical relevance (covariates to be included
in ail models), and if they had a P value 0.25 on univariate analyses that were performed using
Cox proportional hazard (PH) models. No chosen variable had more than 10% ofmissing values,
except for LV ejection fraction and total cholesterol that were considered because oftheir clinical
importance although flot available in 20% of patients. For cadi potential covariate, the PH
assumption was assessed graphically with log-log plots for categorical or Schoenfeld’s residual
plots for continuous variables. There were no time-dependent covariates. Once the selection of
the potential covariates was done for a given outcome, a multivariable Cox PH model was fitted.
The linearity assumption was assessed by log transformation of each continuous variable and
graphical testing against survival time (or time to event). After colinearity checks, covariates
were entered in the multivariable analysis. Formai analyses were performed using heart rate as a
continuous and as a categorical variable as well. In every multivariable model, approximately the
same probability values were obtained with either heart rate as a continuous or categorical
variable. Therefore, and solely for presentational purposes, heart rate was reported in quintiles
because it is clinically more relevant. Results are expressed in hazard ratios for Cox PH model,
compared with the reference group ( 62 bpm) and with 99% confidence intervals (99% CI).
Because of the large number of patients and variables, we used two-tailed probability values of
0.0l as significant differences. Subgroup analyses were performed with heart rate as a
continuous variable. Hazard ratios and 95%CI for each subgroup were calculated for every one
standard deviation increment in heart rate. All analyses were performed with Statistical Package
for Social Sciences (SPSS Inc, Chicago, Illinois).
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RESULTS
Baseline cli aracteristics
The baseline demographic and clinical characteristics of the 24 913 patients included in this study
are presented in Table 3-II. The mean age was higher in the lower heart rate quintiles. The
proportion of males was larger than females in ail groups, with women having a trend towards a
higher resting heart rate. There were higher proportions of dysiipidemic, smoker, hypertensive
and diabetic patients in the higher quintiies. The number of clinically significant diseased
coronary vessels (NCDV) per patient at baseline was higher in the iowest heart rate range.
Ejection fraction (Ef) was iower in patients with a high heart rate at baseline. Patients in the
higher heart rate quintiles received less treatment with 3-blockers and were treated more often
with diuretics. There were no significant differences between the different quintiles with regards
to body mass index (BMI), use of antiplatelets or lipid-lowering drugs.
Multivariable analysis
Overail mortality: Table 3-III displays the adjusted multivariable Cox PH model for total
mortality. Afler adjusting for age, sex, hypertension, diabetes, cigarette smoking, number of
clinically significant diseased coronary vesseis, EF, type of recreational activity, and treatment
with diuretics, beta-blockers, antiplatelets and lipid-lowering drugs, patients with resting heart
rate between 77 and 82 bpm had a significantly higher risk for total mortality hazard
ratio=1.1 6 (99% CI: 1.04-1.28). This effect was even larger for patients with a resting heart rate
83 bpm, with a hazard ratio of 1.32 (CI: 1.19-1.47, Fig. 3.1). Besides a high resting heart rate,
age (hazard ratio=1.05), male gender (1.18), hypertension (1.26), diabetes (1.61), current
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smoking (1.63) and number of diseased coronary vessels per patient (3-vessel disease: hazard
ratio =2.87) were ail independently associated with risk of death. Conversely, a higher EF
(hazard ratio =0.97) and diuretics (0.68) showed a protective effect.
Cardiovascular mortality. Table 3-W shows the hazard ratio for cardiovascular mortality
obtained after a multivariable Cox PH mode! adjusting for the same covariates as for overali
mortality plus body mass index (BMI). A high resting heart rate (83 bpm) was a strong
predictor of cardiovascular mortality (hazard ratio =1.31; CI: 1.15-1.48). Age, hypertension,
diabetes, BMI, cunent smoking and number of ciinically significant diseased coronary vessels
rernained strongly associated with cardiovascular (CV) death. EF and treatment with diuretics
showed a protective effect. Figure 3-2 shows the adjusted cumulative survival curves for
cardiovascular mortality by quintiles ofresting heart rate.
Time to rehospitalizatîon. There was a marked difference in time to first cardiovascular
rehospitalization bctween the two highest heart rate quintiles and the other groups (Fig. 3.3).
Tables 3-V and 3-VI display hazard ratio for independent covariates for time to rehospitalization
due to cardiovascular causes. When comparing patients with heart rates between 77-82 bpm and
83 bpm to patients with a heart rate of 62 bpm, the hazard ratio for time to first
rehospitalization due te any cardiovascular event were respectively 1.11 and 1.14 (F-values
<0.000 1 for both). A higli resting heart rate was aise an independent predictor of time te first
rehospitalization due te angina and CRF (fig. 3-4).
Subgroup analysïs. The association between heart rate and total mertality held true in ail
analyzed subgroups: men vs. women, old (>65 years) vs. young, diabetics vs. non-diabetics,
47
hypertensives vs. normotensives, body mass index > 27 or < 27, those with EF> 50% or EF <
50% and patients treated with J3-blockers vs. those without such a treatment (Figure 3-5).
DISCUSSION
In a study of approximately 25000 patients with suspected or proven CAD, we have found that
resting heart rate is a predictor of overali and cardiovascular mortality, independent of other
known risk factors such as hypertension, diabetes and smoking. The size of the study also
allowed us to adjust the multivariable model for two ofthe strongest predictors ofcardiovascular
mortality and morbidity: the left ventricular EF and the number of clinically significant diseased
coronary vessels. Resting heart rate proved to be an independent risk factor for total and
cardiovascular mortality, even after adjusting for such covariates. Resting heart rate was also a
risk factor for time to rehospitalizations due to CV cause.
There is strong evidence linking an increase in resting heart rate to an increased risk of
cardiovascular morbidity and mortality in the general population [2,7,8]. The relationship
between reduction in heart rate and decrease in mortality has been well established with beta
blockers especially afler MI and in patients with heart failure [3 1-34]. A high heart rate leads to
both greater myocardial oxygen consumption (MVO2) and decreased myocardial perfusion, the
latter by shortening the duration of diastole, which can induce or exacerbate myocardial ischemia.
Heart rate is significantly correlated with the severity and progression of atherosclerosis on
coronary angiography among men who had developed MI at a young age [27,28]. Experimental
data have also demonstrated that a reduction in heart rate can delay the progression of coronary
atherosclerosis in monkeys [20,25]. Beere et al [20] showed that male cynomolgus monkeys
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subjected to sinus node ablation or those with innately low heart rates had significantiy less
coronary atherosclerosis than animais with higher heart rates. These observations are supported
by resuits from the Beta-Blocker Cholesterol-Lowering Asymptomatic Plaque Study (BCAPS)
randomized trial, which have shown that a beta-blocker reduced the rate of progression of carotid
intima-media thickness in asymptomatic patients [29]. More recently, a high heart rate has also
been associated with an increased risk of coronary plaque disniption [35].
Ah of our multivariable models were adjusted for the use of beta-blockers and this aliowed us to
evaluate the independent value ofresting heart rate. This independent relationship held true in ail
subgroups, inciuding men versus women. A high heart rate may reflect an imbalance of the
autonomie nervous system and may therefore be a marker of sympathetic overactivity [14,36-3 8].
In our study, patients with a high resting heart rate had more cardiovascular risk factors than
patients in the howest quintiles. Some investigators have hypothesized that many of the risk
factors (hypertension, diabetes, dyshipidemia, smoking and sedentary) are also related to
sympathetic overactivity [38-40].
Limitations of this study
This study was performed with a population of patients who were referred for cardiac
catheterization; therefore our resuits may flot be applicable to ail other patients with CAD.
Different times of day or circumstances under which basai resting heart rate was measured may
have introduced increased variability of this parameter. Nevertheless, this limitation enhances
rather than diminishes the importance of resting heart rate. The fact that the predictive power of
resting heart rate remains independently of muitivariabie adjustments and potentiai methodologic
issues indicates the robustness ofthe association with morbidity and mortality.
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CONCLUSION
Resting heart rate is a simple measurement with important prognostic implications. Previous
epidemiologic studies demonstrated that high resting heart rate is a strong predictor of total and
cardiovascular mortality in healthy populations. This study extends this observation to a
population of patients referred for coronary angiography for suspected or proven CAD. Patients
with resting heart rate $3 bpm are also prone to more rehospitalizations for cardiovascular
reasons, independently of major risk factors when compared to patients with a resting hazard
ratio 62 bpm. Resting heart rate is a predictor of total mortality and CV disease that should no
longer be neglected in risk flow-charts.
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Table 3-I Description of variables used in thîs study
Variable Definition
RHR in quintiles Obtained manually from radial pulse during 60 seconds at
baseline
Age At time ofenrolment
VARIABLES TO
Gender Males / Females
BE FNCLUDED IN
Use off3-blockade At baseline
ALL MODELS
Ef Single-plane area-length method
EF: EDV - ESV
EDV
Hypertension History of hypertension, confirmed by a physician.
Diabetes mellitus Confirrned by a physician
Cholesterol level Expressed in milligrams per decilitres
BMI Weight in kg divided by the square ofheight in meters
Smoking status Within 3 months prior or after enrolment. Presently,
POTENTIAL
formerly or neyer smoked cigarettes
VARIABLES
NCVD According to CASS criteria
Recreational activity At baseline. Strenuous, moderate, mild or sedentary
Antiplatelet therapy At baseline, mainly ASA or dipyridamole
Diuretics At baseline, mainly furosemide or hydrochiorothiazide
Lipid-lowering dmgs At baseline
Total mortality Vital status obtained ftom FU forms, final survey and NDI
records
CV mortality Cause of death if known, obtained from FU forms, final
survey and NDI records. CV death mcluded cardiac direct,
cardiac contributory and sudden unexplained death
Rehospitalizations due Ever hospitalised for MI, angina, stroke, CHF,
OUTCOMES to CV cause revascularization or rhythm disturbance
MI Ever hospitalised for MI, diagnosis based on ECG andlor
enzyme analysis
Angina Ever hospitalised for angina or chest pain for more than 5
days
Stroke Ever hospitalised for stroke or transient ischemic attack
CHF Ever hospitalised for CHF for more than 5 days
ASA=aspirin; BMIbody mass index; CASS=Coronary Artery Surgery Study; CHF=congestive heart failure; CV=cardiovascular;
ECG=electrocardiogram EDV=end-diastolic volume; EF=ejection fraction; ESV=end-systolic volume; fU=follow-up; MI=myocardial infarction;
NCVDnumber of diseased coronary vessels; NDI=National Death Index; RHRresting heart rate.
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Table 3-II Baseline characteristics divided by resting heart rate in quintiles (n=24913)
62 bpm 63-70 bpm 7 1-76 bpm 77-82 bpm 83 bpm Overali
P-value
Age (years) 54.8 ± 8.9 53.5 ± 9.2 53.0 ± 9.2 52.8 ± 9.3 52.1 ± 9.6 <0.001
Males (%) 79.2 77.4 75.3 74.0 71.6 <0.001
Total cholesterol 227.1 ± 23 1.3 ± 50.0 230.6 ± 232.9 ± 50.6 232.5 ± 53.8 <0.001
(mgldl)* 47.0 50.0
Body mass index 25.8 ± 3.6 25.8 ± 3.6 25.7 ± 3.7 25.8 ± 3.8 26.0 ± 4.2 0.03
(kg/m2)
NCVD 1.6 ± 1.1 1.5 ± 1.1 1.4 ± 1.1 1.4 ± 1.1 1.4 ± 1.1 <0.001
EF (%) 60.5 ± 13.5 59.5 ± 14.6 59.3 ± 15.2 59.0 ± 16.1 58.1 ± 17.6 <0.001
Hypertension(%) 35.7 38.6 41.8 44.2 49.5 <0.001
Diabetes mellitus (%) 9.6 9.9 11.0 11.0 12.5 <0.001
Cigarette Presently 26.7 31.6 33.5 35.1 39.2 <0.001
smoking Formerly 49.6 44.4 41.4 40.2 36.9
Sedentary(%) 37.5 35.7 34.1 33.2 33.4 <0.001
Beta-blockers (%) 69.5 52.2 40.5 33.3 26.4 <0.001
Antiplatelets(%) 6.3 6.1 6.6 6.8 7.1 0.23
Diuretics (%) 20.1 21.5 23.2 24.5 29.1 <0.001
Lipid-lowering drugs 3.6 4.4 4.8 4.2 4.3 0.06
(%)
Continuous variables are expressed in means ± one standard deviation. Categorical variables are
presented as relative frequencies. bpm=beats per mm; EFejection fraction; NCVD=number of
clinically significant diseased coronary vessels per patient.
Differences between different heart rate quintiles at baseline were assessed using chi-square test
for categorical variables and one-way ANOVA for continuous variables.
* Total cholesterol was flot available in 20% of patients and was flot included in multivariable
analyses.
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Table 3-III Mu]tivariable Cox regression survival analysis for total mortality
Total mortality
Hazard ratio (99% CI) Overali P-value
Resting heart rate 62 reference <0.0001
(bpm) 63-70 1.06 (0.97-1.17)
71-76 1.09 (0.98-1.21)
77-82 1.16 (1.04-1.28)
83 1.32 (1.19-1.47)
Age 1.05 (1.04-1.05) <0.0001
Male gender 1.1$ (1.08-1.28) <0.0001
Hypertension 1.26 (1.17-1.35) <0.0001
Diabetes mellitus 1.61 (1.48-1.75) <0.0001
Cigarette smoking presently 1.63 (1.48-1.78) <0.0001
formerly 1.15 (1.05-1.25)
NCVD atbaseline 1 1.64 (1.45-1.85) <0.0001
2 2.18 (1.94-2.45)
3 2.87 (2.56-3.22)
Ejection fraction 0.97 (0.97-0.97) <0.0001
Treatmentwith 13-blockers 1.01 (0.95-1.08) 0.52
Recreational activity strenuous reference <0.0001
moderate 1.01 (0.79-1.29)
mild 1.09 (0.86-1.39)
sedentary 1.22 (0.96-1.54)
Antiplatelettreatment 0.98 (0.87-1.11) 0.79
Diuretic treatment 0.68 (0.64-0.74) <0.0001
Lipid-lowering treatment 1.01(0.87-1.18) 0.76
NCVD=number ofclinically significant diseased coronary vessels.
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Table 3-IV Multivariable Cox regression survival analysis for cardiovascular mortality
CV Mortality
Hazard ratio (99% CI) Overail P-value
<0.0001Resting heart rate (bpm) 62 reference
63-70 1.05 (0.94-1.18)
71-76 1.07 (0.94-1.21)
77-82 1.14 (1.00-1.29)
$3 1.31 (1.15-1.48)
Age 1.04 (1.03-1.04) <0.0001
Male gender 1.0$ (0.97-1.21) 0.04
Body mass index 1.01 (1.00-1.02) <0.01
Hypertension 1.33 (1.22-1.44) <0.0001
Diabetes mellitus 1.53 (1.38-1.70) <0.0001
Cigarette smoking presently 1.49 (1.33-1.66) <0.0001
formerly 1.11 (1.00-1.23)
NCVD atbaseline 1 2.30 (1.94-2.73) <0.0001
2 3.55 (3.02-4.18)
3 4.87 (4.15-5.71)
Ejection fraction 0.96 (0.96-0.97) <0.0001
Treatment with fI-blockers 1.06 (0.98-1.15) 0.04
Recreational activity strenuous reference <0.0001
moderate 1.03 (0.77-1.38)
mild 1.07 (0.81-1.43)
sedentary 1.22 (0.92-1.62)
Antiplatelet treatment 0.96 (0.83-1.11) 0.50
Diuretic treatment 0.63 (0.58-0.69) <0.0001
Lipid-lowering treatment 0.96 (0.80-1.14) 0.55
CV: cardiovascular, NCVD: number ofclinically significant diseased coronary vessels.
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Table 3-V Multivariable Cox regression analysis for time to rehospitalization due to any
cardiovascular cause or acute myocardial infarction
n
Rehospitalization any CV cause Rehospitalization due to MI
Hazard ratio Overail Hazard ratio (99% Overall
(99% CI) P-value CI) P-value
Restingheart rate 62 reference <0.0001 reference 0.73
(bpm) 63-70 0.98 (0.88-1.08) 1.10 (0.89-1.36)
71-76 0.97 (0.88-1.08) 1.03 (0.82-1.29)
77-$2 1.11 (1.00-1.24) 1.02 (0.81-1.29)
83 1.14 (1.02-1.27) 1.07 (0.84-1.35)
Age 1.01 (1.00-1.01) <0.0001 1.00 (0.99-1.01) 0.36
Male gender 0.85 (0.78-0.92) <0.0001 1.09 (0.90-1.33) 0.21
Hypertension 1.22 (1.14-1.3 1) <0.0001 1.45 (1.24-1.68) <0.0001
Diabetes mellitus 1.30 (1.19-1.43) <0.0001 1.46 (1.20-1.77) <0.0001
Cigarette presently 1.25 (1.13-1.37) <0.0001 1.37 (1.12-1.67) <0.0001
smoking formerly 1.10(1.01-1.21) 0.95(0.78-1.16)
NCVD at 1 1.86 (1 .67-2.07) <0.0001 3.30 (2.50-4.36) <0.0001
baseline 2 1.85 (1.66-2.06) 3.86 (2.93-5.08)
3 1.82 (1.64-2.03) 3.91 (2.96-5.16)
Ejection fraction 0.99 (0.99-0.99) <0.0001 0.99 (0.98-0.99) <0.0001
Treatment with -blockers 0.99 (0.92-1.06) 0.76 1.16 (1.00-1.34) <0.01
Recreational strenuous reference <0.000 1 -- --
activity
moderate 1.14 (0.88-1 .46)
mild 1.27 (1.00-1.63)
sedentary 1.38 (1 .08-1.77)
Antiplatelet treatment 0.97 (0.85-1.10) 0.59 0.93 (0.71-1.21) 0.49
Diuretic treatment 0.83 (0.77-0.90) <0.0001 0.97 (0.81-1.15) 0.66
Lipid-lowering treatment 0.91 (0.78-1.06) 0.14
CV: cardiovascular, MI: myocardial infarction; NCVD: number of clirucally significant diseased coronary vessels.
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Table 3-VI Cox regression analysïs for time to rehospitalization due to angina, stroke or
congestive heart failure
CHF: congestive heart failure; CV: cardiovascular; HR:
diseased coronary vessels; RHR: resting heart rate
hazard ratio; NCVD: number of clinically sigmficant
Rehosp due to angina Rehosp due to stroke Rehosp due to CHF
HR (99% CI) Overall HR (99% CI) Overail HR (99% CI) Overali
P-value P-value P-value
RHRin <0.010.016 0.44<62 reference reference reference
bpm 63-70 1.01 (0.90-1.13) 0.99 (0.69-1.42) 0.94 (0.71-1.24)
71-76 0.98 (0.87-1.11) 1.17 (0.81-1.69) 0.99 (0.74-1.32)
77-82 1.09 (0.96-1.23) 1.19 (0.82-1.73) 1.22 (0.92-1.62)
>83 1.12 (0.99-1.27) 1.20 (0.82-1.76) 1.32 (1.007-1.75)
Age 0.99 (0.99-1.00) 0.26 1.04 (1.03-1.06) <0.001 1.04 (1.03-1.05) <0.001
Male gender 0.76 (0.69-0.84) <0.001 0.91 (0.69-1.21) 0.43 0.76 (0.62-0.94) 0.001
Hypertension 1.21 (1.11-1.32) <0.001 1.50 (1.18-1.91) <0.001 1.41 (1.18-1.69) <0.001
Diabetes mellitus 1.28 (1.15-1.43) <0.001 1.78 (1.34-2.35) <0.001 1.60 (1.30-1.97) <0.001
Cigarette Presently 1.29 (1.15-1.43) <0.001
Smoking formerly 1.14 (1.03-1.27)
NCVD 1 1.88 (1.67-2.12) <0.001 1.78 (1.18-2.69) <0.001 1.96 (1.39-2.75) <0.001
2 1.80 (1.60-2.04) 2.12 (1.42-3.16) 2.22 (1.60-3.09)
3 1.64 (1.44-1.86) 2.29 (1.54-3.39) 2.38 (1.72-3.30)
Ejection fraction 0.99 (0.99-1.00) 0.02 0.98 (0.98-0.99) <0.00 1 0.95 (0.95-0.96) <0.001
3-blockertreatment 0.86(0.79-0.93) <0.001 1.21 (0.95-1.54) 0.04 1.21 (1.009-1.45) <0.01
Recreational strenuous reference <0.001 reference <0.01 reference <0.001
activity moderate 0.99 (0.74-1.31) 1.84 (0.56-6.03) 1.36 (0.56-3.33)
mild 1.14 (0.87-1.50) 1.87 (0.58-6.02) 1.72 (0.72-4.12)
sedentary 1.24 (0.94-1.63) 2.45 (0.76-7.90) 2.22 (0.93-5.3 1)
Antiplatelet treatment 0.92 (0.80-1.07) 0.18 -- -- 1.04 (0.73-1.46) 0.76
Diurefic freatment 0.85 (0.77-0.93) <0.001 0.78 (0.60-1.01) 0.014 0.48 (0.40-0.58) <0.001
Lipid-lowenng dmgs 0.88 (0.73-1.05) 0.06 -- 0.95 (0.63-1.44) 0.79
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Figure Legends
Figure 3-l. Adjusted for age, gender, hypertension, diabetes mellitus, cigarette smoking,
clinical!y significant coronary vesse! disease, ejection fraction, recreationa! activity,
treatment with antip!atelets, diuretics, beta-b!ockers and lipid-!owering dntgs.
RHR=resting heart rate.
Figure 3-2. *Adjusted as Fig 3-1 plus body mass index (BMI). CV=cardiovascular;
RHR=resting heart rate.
Figure 3-3 *Adjusted as Fig 3-l. CV=cardiovascular; RHR=resting heart rate. The green and
black lines are superimposed.
Figure 3-4. *Adjusted for age, gender, hypertension, diabetes mellitus, c!inically significant
coronary vessel disease, ejection fraction, recreational activity, treatment with
antiplate!ets, diuretics, beta-b!ockers and lipid-lowering dmgs CHF=congestive
heart failure. The red and green unes are superimposed.
Figure 3-5. $ubgroup analyses on total mortality per SD (12.4 bpm) ofheart rate increment
RHR in quintiles
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Figure 3-1. Adjusted survival curves for overail mortality by RHR quïntiles
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Figure 3-2. Adjusted survïval curves for CV mortahty by RHR quintiles
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Figure 3-3. Adjusted curves for time to rehospitahzatîon due to any CV cause
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Figure 3-4. Adjusted curves for time to first rehospitalïzatïon due to congestive heart faïlure
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Figure 3-5. Subgroup analyses on total mortality per SD (12.4 bpm) of resting heart rate
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ABSTRACT
BACKGROUND High resting heart rate and an attenuated heart rate response to
exercise are predictors of ail-cause mortality in various populations.
The purpose of this study was to evaluate the reiationship between
different heart rate measurernents during exercise treadmiil test
(ETT) and long-tenu overail and cardiovascular (CV) mortality, as
weli as to determine which heart rate pararneter during exercise
contributes the most to clinical outcome in a population of patients
with suspected or proven coronary artery disease (CAD).
METHODS AND RESULTS A total of 2 793 men and women from the Coronary Artery Surgery
Study (CAS$) registry undenvent ETT with interpretabie ST
segment changes within 6 months of index coronary angiogram and
were foiiowed for a median of 15.8 years. Chronotropic
incompetence expressed as a low (< 80) % heart rate reserve
(%HRRes) was a predictor for ail-cause and CV mortality (p <
0.000 1). Patients with a higher %HRRes had a significantly iower
risk of total and CV mortality (hazard ratio = 0.79, CI 0.71 - 0.88, p
< 0.001 for both outcomes for an increment of 1 SD) afier
adjustment for multiple clinicai covariates. Out of ail exercise heart
rate measurements, %HRRes contributed the most to the model.
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CONCLUSIONS Percentage heart rate reserve is the best heart rate predictor for total
and CV mortality in patients with known or suspected CAD and it
should be inciuded routineiy in ail exercise treadmiil test reports.
KEY WORDS: Heart rate; Exercise test; Coronary disease
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CONDENSED ABSTRACT
We followed 2 793 men and women for a median of 15.8 years. Chronotropic incolnpetence
defined as a iow (< $0) percent heart rate reserve was a predictor for ail-cause and cardiovascular
mortaiity (p <0.0001). Patients with a higher reserve had a significantly lower risk of mortality
(hazard ratio = 0.79) after adjustment for multiple covariates. Percentage heart rate reserve is the
best heart rate predictor for mortality in patients with suspected or known CAD and should be
included in ail exercise test reports.
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INTRODUCTION
Exercise treadmili test (ETT) is a widely used and highly valuable diagnostic and prognostic tool.
Different physiological pararneters are used clinically to assess the patient’s response to exercise
such as hemodynamic and electrocardiographic changes and exercise capacity. Arnong the
different heart rate prognostic indexes provided by ETT, percentage heart rate reserve
(%HRRes), a measure of heart rate response to exercise that takes into account resting heart rate,
functional capacity and age, has often been described as a predictor of total and cardiovascular
(CV) mortality (1-10). Other exercise heart rate parameters such as maximal heart rate (HRrnax)
and heart rate recovery (HRRec) (peak heart rate minus post-exercise heart rate) have also shown
an association with total and CV mortality and/or rnorbidity (11-21). It is common to define
chronotropic incompetence as the inability to reach 85% of age-predicted maximal heart rate, yet
its prognostic value against %HRRes has been previously questioned (7, 10). Few recent studies
have compared the relative value of each heart rate measurement or attempted to determine
which one, if any, adds the most incremental prognostic value to conventional risk factors and
ETT parameters in patients with suspected or proven coronary artery disease (CAD).
Furthermore, previous studies had relatively short follow-up periods and excluded patients
treated with beta-blockers.
The purpose of this study was to evaluate the relationship between different heart rate
measurements during BIT and long-term overall and CV mortality afler adjustment for exercise
parameters and other well established CV risk factors such as lefi ventricular EF, angiographic
severity ofCAD and use ofbeta-blockers. Secondly, heart rate measurements were added one at
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a time to a multivariate model containing known CV risk factors to determine which parameter
made the most significant additional contribution to clinical outcome.
METHODS
Study populatïon.
The Coronary Artery Surgery $tudy (CASS) vas a multicenter research program consisting of a
randomized trial and a large registry of patients undergoing coronary arteriography for the
presence of suspected or proven CÀD. From August 1975 through May 1979, 18 894 men and 6
065 women (24 959 overali) underwent coronary angiography at one ofthe 15 participating sites.
from this large pooi of patients, 780 meeting specific selection criteria were randomized into
medical and surgical treatment groups. The present study focuses on ail CASS registry patients.
A detailed description of the CASS design, methods and clinical database has been published
elsewhere (22). Briefly, the registry at each participating center included ail patients whose
primary indication for coronary angiography was suspected or proven CAD. Patients studied
because of suspicion of CAD who were diagnosed to have another form of heart disease were
excluded from the registry. Enrolment was contingent upon obtaining the patient’s written
informed consent, usually before the initial index coronary angiogram. Baseline resting heart rate
was obtained with the patient in a sitting position from a single radial pulse measurement during
60 seconds before initiation of exercise. Variables evaluated in CASS have been previously
described in details (22). The variables chosen for the current study are presented in Table 4-I.
In this study we included only patients undergoing ETT within 6 months of index coronary
angiography. Overail, 6 622 CASS patients underwent ETT, 5 823 of them within the first 6
months after enrolment. We excluded patients with equivocal or non-interpretable $T-segment
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changes either at baseline or at peak exercise. Therefore, we included in this study 2 793 patients
with interpretable $T-segment changes.
Patient follow-up.
The date of enrolment was that of the initial angiographic evaluation. For survival analysis, time
to event was measured as the time period between first ETT and the event (or last follow-up).
Aimual ciinical foliow-up was mandatory for ail patients in the registry. If a patient died, a
detailed report of the circumstances of death was fihled out. Patients were followed annually
through 1982. Thereafter, a final mail survey, to which 94% responded, was carried out between
1988 and 1991. Vital status among non-responders at last follow-up was obtained through 1991
from the National Death Jiidex and, in some cases, from next ofkin, such that the status of 95.8%
of ail CASS patients was known. Median duration of follow-up (and interquartile range) was
15.8 years (13.6-16.9 years).
ETT and heart rate measurements.
Randomized patients were required to undergo maximal ETT at baseline, at 6 and 1$ months, and
at 60 months after enrolment. Although exercise testing was flot mandatory for registry patients,
it was encouraged. ETT was performed on a motor-driven treadmili using a Bruce protocol.
Depending on patient disability, testing was initiated at different stages. The stages at which
exercise was started and stopped were recorded, as was the duration of the test. ST-segment
changes were obtained at baseline, peak exercise and 3 minutes post-exercise. An ischemic
response was considered present if there was 1 mm of horizontal or downsloping ST-segment
depression 80 ms after the J point or if there was 1 mm of additional $T-segment elevation in
leads without pathologic Q waves. Grounds for discontinuation of the test were those of standard
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clinical practice. Additional information on the CASS ETT procedure was published elsewhere
(22-24). Ail measurements were obtained at baseline ETT. Peak or maximal heart rate was
obtained with the patient standing on the treadmili at peak exercise. Post-exercise heart rate was
measured 3 minutes after completion of the Bruce protocol. Heart rate recovery (HRRec) was
calculated as maximum heart rate — heart rate post-exercise. Percent heart rate reserve
(%HRRes) was computed as (HRmax — resting heart rate) / (220 — age — resting heart rate) x
100. Maximal age-predicted heart rate was calculated as 220 — age. Chronotropic incompetence
was defined as a low (< 80) %HRRes achieved andlor as failure to achieve 85% of maximal age
predicted heart rate. Exercise capacity (in metabolic equivalents or METS) was estimated on the
basis ofthe speed, siope and time of exercise on the treadmiil.
Statistïcal analysis.
Because this is a registry database and solely for the purpose of baseiine data presentation,
patients were divided into two groups according to the presence or absence of chronotropic
incompetence. Comparison between groups was performed with the chi-square test for
categorical variables and t-test for continuous variables. Risk factors for mortality or covariates
were first chosen based on their clinical relevance and on univariate Cox proportional hazard
(PH) modeis using a threshold of 0.25 for the p-value. None of the pre-specified chosen
variables had more than 10% missing values. The PH assumption was assessed graphically with
log-log plots for categorical or $choenfeld’s residual plots for continuous variables. There were
no time-dependent covariates. Once the selection ofthe potential covariates was done for a given
outcome, a muitivariable Cox PH mode! was fitted. Linearity assumption was assessed by log
transformation of each continuous variable and graphical testing against survival time.
74
Collinearity checks were done for variables with high clinical suspicion of collinearity. When
collinearity was found, one of the variables was removed, according to clinical relevance. The
models are flot adjusted for resting heart rate since it showed a strong correlation with most
exercise heart rate measurements, given that it is in itself contained in most of these. $imilarly,
exercise capacity in METS was correlated with most heart rate measurements, especialiy HRRes
(r = 0.50, p < 0.0001). The threshold of < 80 %HRRes as a definition for chronotropic
incompetence was based on the ïowest 95% confidence interval value of the ratio of %HRRes to
metabolic reserve in a group of healthy, nonhospitalized aduits (l-10). Because the choice of
cutoff points is somewhat arbitrary, %HRRes as well as ail other heart rate measurements during
ETT was tested as continuous variables to avoid clustering of patients into categories. Resuits
are expressed as hazard ratios, with 95% confidence intervals (CI). for heart rate measurernents,
hazard ratios are expressed as change per one standard deviation (SD). After the Cox PH models
that were most predictive of total and CV mortality were deterrnined, different exercise heart rate
parameters and exercise capacity in METS were independentiy added to each Cox PH mode! to
determine the incremental value of each parameter using the Wald test (25, 26). The parameter
with the iargest Waid test value was considered the one adding the most information to the
model. Subgroup analyses were pianned in advance and tested in Cox PH models as interaction
terms between %HRRes and the different subgroups. We used two-tailed probabiiity values of
0.05 as significant differences. Ail analyses were performed with SPSS v.12 for windows, (SPSS
mc, Chicago, Illinois).
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RESULTS
Patient characteristics.
Table 4-II shows the baseline characteristics of patients according to presence or absence of
chronotropic incompetence. There was no statistical difference in gender, total cholesterol
values, body mass index (BMI), smoking, EF, recreational activity, and treatment with
antiplatelet or lipid-lowering drugs between the 2 patient groups. On the other hand, patients
with chronotropic incompetence were significantly younger, had a worse exercise capacity and
showed a higher proportion of ST abnormalities, diabetes, hypertension and more severe CAD.
In addition, this group showed a higher proportion of patients treated with beta-blockers. Lastly,
HRmax, HRRec and %HRRes were ah significantly lower in patients with chronotropic
incompetence.
Mortality.
0f the 825 deaths, 599 (72.6%) were in the chronotropic incompetence group. Likewise, of the
530 CV deaths, 389 (73.4%) occurred in patients with chronotropic incompetence. Ail heart rate
measurements tested during ETT were significantly associated with ail-cause and CV mortality
when analyzed independently in a univariate analysis. Covariates tested for total and CV
mortality in the muÏtivariate analysis were age, gender, hypertension, diabetes mellitus, total
cholesterol levels, BMI, smoking status, number of clinicahly significant diseased coronary
vesseis, Ef, recreafional activity, ST-segment abnormahities during exercise, and treatment with
beta-blockers. We tested different Cox PH multivariate models for total and CV mortality. Table
4-III shows the Wald test results of each heart rate parameter during exercise and exercise
capacity in METS. We were able to determine which heart rate measurement had the highest
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impact or “weight” in the model by choosing the one with the highest Wald resuit (25,26). Afier
adjustment for multiple covariates, each heart rate measurement during ETT was significantly
associated with the tested outcomes as were the number of METS. However, %HRRes was the
covariate which contributed the most to each model. Coefficient estimates for ail other covariates
included in each model did flot change significantly when testing different heart rate
measurements. Table 4-IV shows the multivariate analysis for total and CV mortality. A higher
%HRRes was significantly associated with lower total and CV mortaÏity rates with a hazard ratio
(and 95% CI) of 0.79 (0.71-0.88) for both outcomes (p< 0.001), for each SD increment in
%HRRes. Chronotropic incompetence defined as inability to reach 85% of the APMHR was
predictive of total mortality as well as for CV mortality (hazard ratio 1.34 and 1.31
respectively, p <0.01 for both outcomes). When chronotropic incompetence was defined
categorically as the inability to reach 80 %HRRes, it showed a hazard ratio of 1.45 (1.20-1.74)
for total mortality and 1.50 (1.19-1.89) for CV mortality with p values < 0.01 for both outcomes.
Additionally, higher maximal heart rate and heart rate recovery were associated with lower total
mortality (hazard ratio = 0.83 and 0.81 respectively, p <0.001) and CV mortality (hazard ratio =
0.83, p <0.001 for both outcomes) for each SD increment. Figures 4-1 and 4-2 show adjusted
cumulative survival curves for ah-cause and CV mortality according to presence or absence of
chronotropic incompetence when defined as inability to reach either 80% of HRRes or 85% of
age predicted maximal heart rate.
Subgroup analysis.
The tests for interaction terms between % heart rate reserve and gender, age, hypertension,
diabetes melhitus, BMI, EF and treatment with beta-blockers were planned pre hoc. The only
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statistically significant interaction noted was between %HRRes and Ef (p = 0.018 for
interaction). Iii the 589 patients with Ef < 50%, percent ERRes did not show a predictive value
for total mortality (hazard ratio = 0.92 (0.79-1.07)). In patients with EF> 50%, percent HRRes
showed a significant association with total mortality with a hazard ratio of 0.76 (0.69-0.85, p <
0.001). There was no interaction between ail other subgroups including patients receiving or not
treatment with beta-blockers.
DISCUSSION
In this large multicenter registry, with a median follow-up of 15.8 years, measurements during
exercise of maximal heart rate, percent age-predicted maximal heart rate, heart rate recovery and
%HRRes were ail significantly related to total and CV rnortality, irrespective of other major CV
risk factors and ETT parameters. When testing their individual additional value in a Cox PH
multivariate model for total and CV deaths, %HRRes was the variable yielding the highest
contribution among ah heart rate measurements and exercise capacity in METS. %HRRes was an
independent predictor of these hard endpoints, even afler adjustment for ST-abnormalities at peak
exercise, severity of CAD, LVEf, use of beta-blockers, and other standard CV risk factors. for
each standard deviation increment in %HRRes, there was a 21% risk reduction in total and CV
mortality.
Several exercise laboratories report tests in which patients fail to reach 85% of their APMHR as
being “non-diagnostic”. Yet, an association between chronotropic incompetence and adverse
outcomes has been studied in different populations (1-7,10,12,27). Most of these studies
excluded patients on beta-blockers, had relatively short follow-up periods, and many were done
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in rather selective populations. In contrast, our study population consisted of nearly 25 000
patients referred for coronary angiography. As a result of the high number of patients and the
comprehensiveness of data acquisition in the CA$$ database, we were able to include many
covariates in our models, such as beta-blockers and other pharmacological, clinical, angiographic
and follow-up variables which differentiate this study from previous publications. The median
follow-up in our study (15.8 years) was much longer than in previous ones (2-3 years of follow
up in most studies). It was interesting flot to find an interaction on mortaÏity between %HRRes
and beta-blockers (p = 0.53). As expected, we found %HRRes to be significantly lower in
patients taking beta-blockers than in those not taking these drugs (means of 62.65 vs. 78.46 p <
0.001). It is known that patients taking beta-blockers show a non-standardized blunted, but
otherwise normal heart rate response to exercise and different formulas for assessing this
chronotropic response have been developed (27, 28). Therefore, %HRRes and other chronotropic
incompetence parameters could be of prognostic value and must be further investigated even in
patients taking beta-blockers. Such patients should not be mereÏy excluded from ETT analyses.
%HRRes remained an independent predictor of mortality even after adjusting for confounders
such as EF and other CV risk factors and this is in concordance with previous studies (3).
Nevertheless, there was an interaction in our study between %HRRes and Ef. This can be
explained by the depressed baroreflex sensitivity or affected cardiac sympathetic responsiveness
in patients with ventricular dysfunction (29-32). Peak heart rate and heart rate recovery have also
been described as prognostic factors of overail mortality and CV events. The simplest measure
of chronotropic response to exercise is peak or maximal heart rate. Even if it has in itself been
identified as a prognostic marker (12), peak heart rate has its limitations, mainly due to its
relationship to age and functional capacity. 0f the four measurements of heart rate performance
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during ETT in our population, %HRR contributed the most to each multivariate model.
Therefore %HRRes, and flot failure to reach 85% APMHR, should probably be used when
assessing heart rate response to exercise. %HRRes has been reported in the Framingham and
other populations to be a better marker of chronotropic incompetence (7, 10). Finally, we found
heart rate recovery at 3 minutes also to be associated with ail-cause and CV mortality. This is in
agreement with previous studies in different populations (13-21, 33-42).
The physiology of heart rate response to exercise is complex and depends mostly on sympathetic
and parasyrnpathetic tone and neurohormonal activation. It lias been suggested that chronotropic
incompetence is a rnarker of autonomic dysfunction, which is in itself correlated with higher
mortality (38, 43-5 1). In a recent study, Jouven et al reportcd that patients with a blunted heart
rate response to exercise had a six-fold increase in relative risk for sudden death, which further
supports the aforementioned mechanism (52). The ischemic myocardium might trigger the
Bezold-Jarisch reflex from meclianoreceptors in the left ventricular wall and therefore elicit an
altered parasympathetic response to exercise in patients with CAD (53). The hypothesis of sinus
node ischemia does flot seem plausible and some authors have reported no statistical association
between proximaÏ right coronary artery disease and the various chronotropic parameters (1).
However, the specific mechanisrns by which patients with chronotropic incompetence have an
increased risk in total and CV mortality, independent of the risk associated with traditional risk
factors, remain unclear.
Study ]imitatïons.
There have been several medical advances since CASS was compÏeted. Nevertheless, the high
quality of data collection and extensive follow-up in CA$$ allowed us to fully appraise the long-
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term value of heart rate measurements during ETT. Most importantly, in addition to
conventional CV risk factors and medications, we were able to adjust for important variables
such as ST abnormalities at peak exercise, EF and severity of CAL). Ail patients included in
CASS underwent angiographic evaluation, which introduces a selection bias. Finally, it was flot
the purpose of the present study to analyze therapeutic approaches for impaired chronotropic
incompetence.
CONCLUSIONS
Chronotropic incompetence expressed as failure to reach 80% of heart rate reserve during
exercise is associated with an increased risk of total and CV mortality in patients with known or
suspected CAD. This risk persists after adjusting for ST abnormalities, exercise capacity, EF,
severity of CAD and other important CV risk factors. When tested against other heart rate
measurements during ETT, %HRRes was the measurement contributing the most to ail models.
We believe that clinicians should give more importance to heart rate behavior during exercise and
that percent heart rate reserve should be part of standardized measurements reported during ETT.
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Table 4-I. Definitions of Variables
Variable Definition
Age At ETF.
Gender Male / Female.
Use of f3-blockade At ETT.
Hypertension History of hypertension confirmed by a physician at
baseline.
Diabetes mellitus History of diabetes confirmed by a physician at
baseline.
Cholesterol level Expressed in milligrams per deciliters at bascline.
Body mass index Weight in kg divided by the square of height in meters
at baseline.
Smoking status Within 3 months prior to or afier enrolment. Presently,
formerly or neyer smoked cigarettes.
NCVD According to CASS criteria at first angiogram.
LVEF Directly measured by single-plane area-length method
LVEF: EDV ESV
EDV
Recreational activity At baseline. Strenuous, moderate, mild or sedentary.
Antiplatelet therapy At baseline.
Lipid-lowenng dmgs At baseline.
Metabolic equivalents (METS) Estimated by the total time completed in the final
stage, speed and siope oftreadmill.
ST abnormality at peak exercise 1 mm of horizontal or downsloping ST-segment
depression 80 ms after the J point or if there vas 1
mm of additional ST-segment elevation in leads
without pathologie Q waves.
Maximal heart rate dunng ETf (HRmax) ECG at peak exercise.
Heart rate recovery (HRRec) Maximal heart rate during exercise minus post-exercise
heart rate without cool-down period, 3 min afier a
modified Bmce protocol.
% ofheart rate reserve (%HRRes) ((Maximal heart rate minus heart rate at rest) /
(220 minus age minus heart rate at rest)) x 100.
Total mortality Vital status obtained from follow-up forms, final
survey and NDI records.
Cardiovascular mortality Cause of death if known, obtained from FU forms,
final survey and NDI records. CV death included
cardiac direct, cardiac confributory and sudden
unexplained death.
EDV = end diastolic volume; ESV = end systolic volume; ETT = exercise treadmili test; FU =
follow-up; LVEF = lefi ventricular ejection fraction; NCVD = number of clinically significant
coronary vessel disease; NOl = national death index.
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Table 4-II. Baseline Characteristics by Chronotropic Incompetence
No Chronotropic Chronotropïc p Value
Incompetence Incompetence
n 1105 (39.6%) n = 1 688 (60.4%)
Age (yrs) 54.9 ± 9.2 51.0 + 10.0 <0.001
Male gender $71 (78.8) 1 380 (81.8) 0.05
Hypertension 242 (22.3) 477 (28.8) <0.001
Diabetes mellitus 64 (5.8) 154 (9.1) 0.001
Total cholesterol (mg/dl) 230.6 ± 49.9 234.0 * 49.7 0.05
Bodymass index 25.6+3.5 25.8+3.5 0.11
Smoking status presently 448 (40.5) 696 (41.2) 0.18
formerly 410 (37.1) 662 (39.2)
NCVD 0 470 (42.5) 368 (2 1.8) <0.001
1 296 (26.8) 376 (22.3)
2 219(19.8) 439(26)
3 120 (10.9) 505 (29.9)
Ejectionfraction(%) 59.2+ 11.6 59.2± 12.1 0.90
Recreational strenuous 49 (4.5) 47 (2.8) 0.06
activity moderate 225 (20.5) 316 (18.8)
mild 456(41.5) 718(42.8)
sedentary 370 (33.6) 597 (35.6)
Antiplatelet treatment 49 (4.4) 75 (4.4) 0.99
Lipid-lowering drugs 46 (4.2) 80 (4.7) 0.47
Beta-blocker treatment 82 (7.4) 452 (26.8) <0.001
Exercise capacity in METS 9.9 + 3.0 6.9 + 3.0 <0.001
SI abnormalities at peak 332 (37.1) 830 (5 8.0) <0.001
exercise
Maximal heart rate (bpm) 165.5 ± 12.3 123.4+ 18.5 <0.001
Heart rate recovery (bpm) 59.7 ± 14.8 42.4 ± 14.2 <0.001
Heartratereserve(%) 101.7+ 16.1 53.8± 16.6 <0.001
Chronotropic incompetence defmed as either inability to reach either 85% of age-predicted
maximal heart rate or < 80% ofheart rate resewe.
Continuous variables are expressed as mean ± one standard deviation. Categorical variables
expressed in absolute numbers (%; denominator may vary because of missing values). Bpm =
beats per minute; NCVD = number of clinically significant coronary vessel disease.
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Table 4-III. Wald Test Resuits of Different Heart Rate Parameters and Number of METS
Durïng Exercise
Overali Mortalïty Cardiovascular Mortality
Maximal heart rate 20.9 11.9
Heart rate recovery 23.7 14.4
% age-predicted maximal 12.0 6.5
heart rate
METS 14.3 8.7
% heart rate reserve 24.7 15.3
Resuits with the highest values are the ones contributing the most to the model being tested,
which in this case is % of heart rate reserve. Based on multivariate models adjusted for age,
gender, hypertension, diabetes mellitus, total cholesterol, body mass index, smoking, clinically
significant coronary vessel disease, ejection fraction, recreational activity, ST abnormalities
during peak exercise and treatment with beta blockers. See text for details.
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Table 4-IV. Multivariate Analysis for Total and Cardiovascular Mortality
Total Mortality Cardiovascular Mortality
Age
Male gender
Hypertension
Diabetes mellitus
Total cholesterol
Body mass index
Smoking Presently
Formerly
NCVD 1
2
3
Ejection fraction
Physical activity
Beta-blockers
ST abnormalities
peak exercise
Hazard Ratio
(95%CI)
1.00 (0.99-1.01)
1.16 (0.90-1.49)
1.34 (1.13-1.58)
1.69 (1.34-2.14)
1.00 (0.99-1.00)
1.00 (0.98-1.02)
1.50 (1.19-1.88)
1.12 (0.89-1.42)
1.62 (1.23-2.15)
2.21 (1.68-2.92)
3.24 (2.45-4.29)
0.97 (0.97-0.98)
0.75 (0.48-1.16)
0.94 (0.77-1.14)
at 0.89 (0.76-1.05)
Overail
p Value
0.38
0.23
0.01
<0.001
0.87
0.87
<0.001
<0.001
<0.001
0.63
0.54
0.18
Overali
p Value
0.52
0.46
<0.001
<0.01
0.34
0.75
0.001
<0.001
<0.001
0.86
0.17
0.26
Heart rate reserve 0.79 (0.71-0.88)
(for each increment
of 1 SD)
<0.001 0.79 (0.71-0.88) <0.001
Hazard Ratio
(95 %CI)
1.00 (0.99-1.01)
1.12 (0.81-1.54)
1.52 (1.24-1.86)
1.50 (1.11-2.02)
1.00 (0.99-1.00)
1.00 (0.97-1.03)
1.43 (1.09-1.89)
1.02 (0.76-1.37)
2.05 (1.38-3.06)
3.39 (2.3 1-4.98)
5.16 (3.50-7.62)
0.97 (0.96-0.98)
0.79 (0.45-1.37)
0.84 (0.65-1.08)
0.89 (0.73-1.09)
CI = confidence interval; NCVD = number of clinically significant coronary vesse! disease; SD =
standard deviation.
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Figure Legenils
Figure 4-1. Adjusted suwival cunres for total mortality according to presence or absence of
chronotropic incompetence. *Adjusted for age, gender, hypertension, diabetes mellitus, total
cholesterol, body mass index, smoking status, clinically significant coronary vessel disease,
ejection fraction, recreational activity, ST-abnormalities during peak exercise and treatment with
beta blockers. **Defined as inability to reach either 85% ofage-predicted maximal heart rate or <
80% ofheart rate reserve.
Figure 4-2. Adjusted survival curves for cardiovascular (CV) mortality according to presence
or absence ofchronotropic incompetence. *Adjusted as Fig. 1. ** Defined as Fig. 1.
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5. GENERAL DISCUSSION AND CONCLUSION
5.1 Main resuits and original contribution
In the first of the original articles we have proven that in a population of patients with stable
CAD, a higher resting heart rate was significantly associated with long-term higher total and CV
mortality as well as a higher rate of CV rehospitalizations independentiy of major risk factors.
This association was equally strong in ail sub-groups studied such as men vs. women, different
age groups, diabetics vs. non-diabetics, hypertensives vs. normotensives, BMI > 27 or < 27, EF
>50% vs. <50% and patients treated with or without t3-blockers.
In the second original article presented in this thesis we were able to prove the independent
prognostic vaiue of percent heart rate reserve during ETT in a population of patients with proven
or suspected CAD. Chronotropic incompetence expressed as failure to achieve 80% of heart rate
reserve was a strong predictor of total and CV mortaiity. Furthermore, when compared with other
easily and currently availabie heart rate parameters such as maximal heart rate, age-predicted
heart rate and heart rate recovery, %HRRes had the best predictive value.
5.2 Confounding variables
Due to the large number of patients we were able to correct our multivariate models for many
potential confounders, ail of them with ciinical impact in this population. Among the most
relevant ones are ail standard CV risk factors (i.e. HTN, DM, choiesteroi values, smoking),
number of clinically significant coronary artery disease, Ef, exercise capacity in METS and ST
segment changes during ETT.
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5.2.1 -adrenergic receptor antagonists
An important contribution in this study was the inclusion of patients taking f3-adrenergic receptor
antagonists. Most studies focusing on the effect of heart rate would exciude these patients.
However, the mai ority patients of with stable CAD are prescribed with 3-blockers. Therefore, we
thought it would be interesting to actually test the interaction effect of these drugs, if any,
between different heart rate parameters and outcomes. The interaction terms were not significant
in our total or CV mortality models, neither the RHR x /3-blockers nor ¾ HRRes x fi-blockers
terms. The protective effcct of a lower RHR in our study is flot due to the negative chronotropic
effect of beta-blockers since this was also noted in patients not taking them. Our study lends
further support to the relevance of prospectively testing in future randomized clinical trials the
effect of selectively lowering heart rate to reduce CV mortality and rnorbidity.
It is well known that patients treated with f3-blockers show a blunted but otherwise normal heart
rate response to exercise. Most maximal heart rate formulas during exercise were validated in
normal subjects without any treatment, thus without E3-blockers. Brawner et al developed and
validated an age-specific equation to predict HRmax in patients with CAD who are receiving f3-
blockade therapy (99). They studied a registry of patients with a history of myocardial infarction
or revascularization procedure; preserved lefi ventricular function; age 40 to $0 years; sinus
rhythm; and a graded treadmill test with a respiratory exchange ratio ?1 .10. Data were split
according to date of entry so as to serve as equation development and validation. Linear
regression was used to develop the equation to predict HRmax, based on age, and to calculate the
correlation coefficient of the prediction equation among the cross-validation group. The resultant
prediction equation was HRmax 164
- 0.7 x age (r2 = 0.13), with a standard error of the
estimate of 18 per minute. Based on these results and on the lack of interaction in our study,
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further research conceming heart rate response to exercise needs to be performed in patients
taking f3-blockers.
5.2.2 Ejection fraction
In the first article, the protective effect of a lower RHR was seen across ail subgroups including
those with EF >50% or Ef <50%. That is to say, that no matter what the left ventricle Ef is,
patients will stili benefit from a lower RHR. As a matter of fact, most previous heart failure trials
with f3-blockers and other drugs with negative chronotropic effect demonstrated a marked benefit
among subgroups of patients with high RHR (100). Heart failure trials with non-t3-blocker
treatment that increased heart rate tended to increase mortality. SimiÏarly, f3-blockers with
intrinsic sympathomirnetic activity reduce RHR by less than 5-6 bpm and have had a negligible
effect on mortality in heart failure patients.
There was a significant interaction between left ventricle Ef and %HRRes for total mortality.
The protective effect of a normal chronotropic response was only noticed in patients with nonnal
Ef. Nevertheless, the purpose of a multivariate Cox PH survival analysis is to correct for possible
confounders, indeed the %HRRes prognostic value for total and CV mortality remained
significant even afier inclusion of EF in the model. Multiple abnormalities in autonomic
regulation are found in patients with CHF and they certainly play a role in heart rate regulation
during exercise. Racine et al from the Montreal Heart Institute studied the effect of 3-blocker
therapy in patients with decreased HRRec after exercise in patients with CHF and a mean left
ventricular EF of 26% (82). They found HRRec significantly attenuated in patients with CHF in
comparison to normal individuals. 0f note, this difference was flot significant when corrected for
HRRes. Treatment with 3-blockers did not improve HRRec, but it did improve Ef from a
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baseline 26% to 28.8% afier 6 months of treatment. (j) = 0.01). This suggests that, despite
improving EF, the autonomic balance remained altered.
5.3 Study limitations
The main limitations of each article were outlined in each discussion section. This is a
retrospective analysis of a prospectively collected database (non-concurrent prospective study or
historical cohort). It is flot the purpose of this thesis to define the mechanisms of the association
between heart rate at rest or during exercise and long-term rnortality. With this type of analyses
an epidemiological approach is suggested instead. Nevertheless, the theoretical
pathophysiological mechanisms responsible for this association were discussed in the discussion
section of each article and in this thesis introduction.
A number of potential biases must be considered in historical cohorts. Some of the major biases
are the following: bias in assessment of the outcome, information bias, bias from non-response
and losses to follow-up, and analytic bias. Certainly, the design of cohort studies does flot allow
for correction ofunkown baseline variables that could be ofprognostic importance.
CASS was a comprehensive registry of patients followed annually until May 1979. Evidently,
medical care has much evolved since then and the impact of resting heart rate and heart rate
during exercise on point estimates of mortality could be overestimated if compared to current
practices. This does not underscore the magnitude of recognizing heart rate as an important risk
factor in the assessment of cardiovascular health. Many other risk factors are stili significant even
if their impact lias been counterbalanced with advances in medical treatment. More importantly, a
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high resting heart rate can be therapeutically targeted, as is the case for other risk factors. Some
current randomized clinical trials are assessing the impact of exclusively reducing high heart rate.
5.4 General conclusions
From different perspectives, the relationship between resting heart rate and its role in metabolic
regulation is very interesting, leading to the theoretical concept of a predetermined number of
heartbeats in a lifetime. In patients with stable CAD a lower heart rate has proven beneficial
effects in preventing angina and improving lifestyle. Nevertheless, the repercussion on total and
CV mortality of a lower RHR had neyer been studied in this population. We have proven in this
study that RHR is an independent predictor for total and CV mortality in patients with stable
CAD. The beneficial effect of exclusive heart rate reduction in this population should be further
addressed in prospective, randomized clinical trials.
In addition, the added value of heart rate behavior during exercise has been neglected and many
physicians concentrate on other exercise parameters. We were able to determine % heart rate
reserve as the best independent predictor of total and CV mortality in patients with stable CAD
undergoing ETT. We believe that percent heart rate reserve should be part of standardized
measurements reported during ETT.
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